International Journal of Molecular Sciences Review Understanding MAPK Signaling Pathways in Apoptosis Jicheng Yue 1 and José M. López 2, * 1 School of Biology and Basic Medical Sciences, Soochow University Medical College, 199 Ren’ai Road, Suzhou 215123, China; jicheng_yue@suda.edu.cn 2 Institut de Neurociències, Departament de Bioquímica i Biologia Molecular, Unitat de Bioquímica, Facultad de Medicina, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Barcelona, Spain * Correspondence: josemanuel.lopez@uab.cat; Tel.: +34-935-814-278  Received: 5 February 2020; Accepted: 25 March 2020; Published: 28 March 2020  Abstract: MAPK (mitogen-activated protein kinase) signaling pathways regulate a variety of biological processes through multiple cellular mechanisms. In most of these processes, such as apoptosis, MAPKs have a dual role since they can act as activators or inhibitors, depending on the cell type and the stimulus. In this review, we present the main pro- and anti-apoptotic mechanisms regulated by MAPKs, as well as the crosstalk observed between some MAPKs. We also describe the basic signaling properties of MAPKs (ultrasensitivity, hysteresis, digital response), and the presence of different positive feedback loops in apoptosis. We provide a simple guide to predict MAPKs’ behavior, based on the intensity and duration of the stimulus. Finally, we consider the role of MAPKs in osmostress-induced apoptosis by using Xenopus oocytes as a cell model. As we will see, apoptosis is plagued with multiple positive feedback loops. We hope this review will help to understand how MAPK signaling pathways engage irreversible cellular decisions. Keywords: apoptosis; protein kinases; caspases; signaling; MAPK; p38; JNK; ERK; oocytes; feedback loops 1. A Simple Introduction to MAPK Cascades Over three decades have passed since Sturgill and Ray detected and characterized a new serine/threonine kinase, which was termed MAP kinase (MAPK) as it catalyzes the phosphorylation of microtubule-associated protein 2 (MAP-2) in insulin-treated 3T3-L1 adipocytes [1,2]. The MAP kinase was cloned two years later and named extracellular signal-regulated kinase 1 (ERK1) [3]. From then on, a super kinase family represented by ERK1 aroused a lot of interest in the scientific circles. As most family members are involved in processing signals stimulated by growth factors, the super kinase family was termed “mitogen-activated” protein kinase (MAPK) [4]. Members of the MAPK family share related structures and biochemical properties, especially as they are activated by dual phosphorylation on a tripeptide motif (Thr-X-Tyr) located in the kinase activation loop (T-loop) through a so called three-tiered MAPK cascade that comprises a MAPK, a MAPK kinase (MAPKK or MAP2K), and a MAPK kinase kinase (MAPKKK or MAP3K) [5]. On the contrary, MAPK inactivation is mediated by phosphatases through the dephosphorylation of threonine and/or tyrosine residues within the activation loop. Dephosphorylation can be achieved by serine/threonine phosphatases [6,7], tyrosine phosphatases (reviewed in [8]), or dual-specificity phosphatases (DUSPs) that dephosphorylate both the Thr and Tyr residues within the activation loop (reviewed in [9]). In addition, for accurate signal transmission both MAPK activation and inactivation are monitored by some specific scaffold proteins. In mammalians, 14 MAPK members divided into 7 subgroups have been identified, including four conventional MAPK subgroups that work in a typical three-tiered module, Int. J. Mol. Sci. 2020, 21, 2346; doi:10.3390/ijms21072346 www.mdpi.com/journal/ijms Int. J. Mol. Sci. 2020, 21, 2346 2 of 22 such as extracellular-regulated kinase (ERK1/2), C-Jun N-terminal kinase (JNK), p38 MAPK, and ERK5, and three atypical MAPK subgroups that do not follow the classical three-tiered, dual-phosphorylation signaling structure, such as ERK3/4, ERK7/8, and nemo-like kinase (NLK) (reviewed in [10]). Over the past 30 years, extensive research has shown that MAPKs play a pivotal role in converting extracellular stimuli into a wide range of cellular responses, including cell growth, migration, proliferation, differentiation, and apoptosis. Among them, JNK and p38 MAPK are activated most notably following cell exposure to stress evoked by a variety of physical, chemical, and biological stress stimuli, whereas ERK1/2 cascades mostly process cell growth factor-stimulated signaling [5,11]. Here, we present the recent progress about the role of the three prototypical MAPK groups in apoptosis. The dual nature of MAPKs in cell death (pro- or anti-apoptotic) and their dynamics will be discussed. We will consider the signaling properties of MAPKs in response to different stimuli, and the presence of multiple positive feedback loops that promote irreversible processes in the cell. Finally, we will explain the new insights into the MAPK function in apoptosis that were obtained by using Xenopus oocytes as a cell model. We hope this review will help to better understand the complex world of MAPKs. 2. Both JNK and p38 MAPK Cascades Mediate Pro-Apoptotic Processes The stress-activated JNKs and p38 MAPKs play key roles in balancing cell survival and death in response to both extracellular and intracellular stresses (reviewed in [12]). Extensive research in apoptosis suggests that these kinases function in a cell context-specific and cell type-specific manner to integrate signals at different transmission points though both transcription-dependent and transcription-independent mechanisms, which would eventually converge on caspase activation. Generally, caspases can be activated by either an extrinsic pathway or an intrinsic pathway; the former is initiated by cell-surface death receptors stimulated by their corresponding ligands, and the latter is induced by protein release from the mitochondrial outer membrane due to pro-apoptotic Bcl-2 (B-cell lymphoma 2) family proteins mediating mitochondrial permeabilization [13]. Cytochrome c release from the outer mitochondrial membrane is a critical step in the intrinsic apoptotic pathway. Several Bcl-2 family proteins, both pro- and anti-apoptotic groups, are under the control of JNK and/or p38 MAPK cascades at a transcriptional and/or post-transcriptional level. Three different jnk genes and four different p38 genes have been described in vertebrates, and more “flavors” can be obtained by selective transcription and alternative splicing. However, the role of different JNK and p38 isoforms in the regulation of apoptosis is not so clear and will not be treated in this review. We will consider only the role of JNK1-1 and JNK1-2 in osmostress-induced apoptosis (Section 8). 2.1. Transcriptional Regulation A diverse set of JNK and p38 MAPK substrates that promote apoptosis have been identified and validated [14,15]. A variety of transcription factors have been reported to be regulated by JNK and p38, which result in increased expression of pro-apoptotic proteins and decreased expression of anti-apoptotic proteins [14,16]. A major JNK target is transcription factor AP-1 (activator protein 1), a dimeric (homo- or heterodimer) complex that comprises members of the Jun (c-Jun, JunB, and JunD), Fos (c-Fos, FosB, Fra1, and Fra2), ATF (activating transcription factor), and MAF (V-maf musculoaponeurotic fibrosarcoma) protein families. The diverse combinations of AP-1 determine distinct gene transcriptional profiles under the control of JNK and/or p38 MAPK cascades. For example, c-Jun can be phosphorylated by JNK [17] and p38 [18], and the activated c-Jun can autoregulate its own expression in a positive regulatory loop through a c-Jun/AP-1 enhancer element in its promoter [19]. AP-1 regulates a wide range of cellular processes, including cell proliferation, differentiation, cell survival, and apoptosis [20,21]. Although AP-1 activation is associated with apoptotic scenarios, its role in ensuring cell survival seems equally important. The pro- or anti-apoptotic role of AP-1 activation seems to be dependent on the cellular and extracellular context [22]. In addition to AP-1, one of the best-known transcription factors regulated by JNK and p38 MAPK cascades in apoptosis is p53 tumor suppressor protein. In stressed cells, JNK-mediated phosphorylation can stabilize and activate p53 and Int. J. Mol. Sci. 2020, 21, 2346 3 of 22 thus promote programmed cell death [23]. Like the c-Jun component of AP-1, the transcription factor p53 works in combination with other proteins. It was reported that p53-p73 dimerization is critical in the induction of apoptotic cell death, particularly in response to the JNK-mediated cell stress response. Activated JNK phosphorylates p53 at Thr81 in the proline-rich domain (PRD), which enables the dimerization of p53 and p73. The p53-p73 dimer facilitates the expression of several pro-apoptotic target genes, such as puma and bax [24]. However, in HIV-1 envelope glycoprotein complex (Env)-induced apoptosis, p38 MAPK promotes cell death through phosphorylation of p53 at Ser46 instead of Thr81 [25], which may imply a distinct dimerization status of p53. An identified p53 partner protein targeted by p38 MAPK cascade is p18 Hamlet [26]. In response to genotoxic stresses induced by UV or cisplatin treatment, p18 Hamlet is phosphorylated and stabilized. Phosphorylated p18 Hamlet dimerizes with p53 and stimulates the transcription of several pro-apoptotic p53 target genes, such as puma and noxa [26]. It has also been reported that p53 is positively self-regulated in a JNK-dependent manner via suppression of Wip1 (wild-type p53-induced phosphatase 1), a p53 inhibitor encoded by the gene ppm1d [27]. Even if p53 is a major JNK/p38 MAPK substrate in promoting apoptosis, in some contexts, p53 is not phosphorylated by activated JNK or p38 MAPK. In eIF5A1 overexpression-induced cell death, JNK and p38 MAPK cascades promote apoptosis independently of p53 activation [28]. Similarly, in LPS/D-Gal (lipopolysaccharide/d-galactosamine)-induced liver injury, the AMPK (50 adenosine monophosphate-activated protein kinase) signaling pathway promotes apoptosis through JNK activation, but the level of p53 remains unchanged [29]. Besides AP-1 and p53, other transcription factors are implicated in MAPK-induced apoptosis. For instance, JNK-catalyzed phosphorylation can promote the release of the transcription factor FoxO1 (forkhead box protein O1) from its blocking protein 14-3-3 in oxidative stress-induced mouse follicular granulosa cell apoptosis [30]. These data support the idea that MAPK signaling pathways function in a cell context-specific and cell type-specific manner to promote apoptosis. 2.2. Post-Transcriptional Modifications In addition to regulating the levels of the expression of apoptotic proteins, JNK/p38 MAPK cascades also regulate their functions directly in both extrinsic and intrinsic apoptotic pathways. The extrinsic pathway, or death-receptor pathway, can induce caspase-8 activation and apoptosis independently of Bcl-2 family members. However, in some cells, the extrinsic pathway can induce caspase-8-mediated cleavage of the pro-apoptotic BH3-only protein Bid (BH3 interacting-domain death agonist). The C-terminal truncated form of Bid (tBid) translocates to mitochondria and induces the release of cytochrome c, which in turn induces further caspase activation (caspase-9 and the effector caspases-3, -6, and -7) through the intrinsic pathway [31]. Therefore, the extrinsic and intrinsic pathways of apoptosis can converge in the mitochondria. It has been reported that JNK phosphorylates the E3 ubiquitin ligase iTCH (itchy homolog), which in turn promotes ubiquitination-mediated degradation of the caspase-8 inhibitor c-FLIP (cellular FLICE (FADD-like IL-1β converting enzyme) inhibitory protein) [32]. Intriguingly, TNFα (tumor necrosis factor alfa) treatment activates the JNK cascade, which induces caspase-8-independent cleavage of Bid; the resultant fragment of Bid (jBid), distinct to t-Bid, translocates to mitochondria and selectively promotes the release of Smac/DIABLO (second mitochondria-derived activator of caspases/direct inhibitor of apoptosis protein-binding protein with low pI) [33]. It has also been reported that JNK protects Bid from caspase-8-mediated cleavage through the phosphorylation of Bid at Thr59, but full-length phosphorylated Bid is cleaved by an unknown protease to generate jBid [34]. More studies are necessary to identify this protease and uncover its function during cell death. p38 and JNK can also regulate autophagy programs. The activation of RIPK (receptor-interacting serine/threonine-protein kinase) and JNK can induce autophagic cell death [35]. Although autophagy was initially identified as a cell survival mechanism during nutrient starvation, autophagy plays high context-specific roles in mediating cell death. The interplay between autophagy-dependent cell death and other types of cell death was reviewed recently [36,37]. The role of JNK in autophagy and other types of cell death was also reviewed [38]. Recently, it has been reported that sustained p38α Int. J. Mol. Sci. 2020, 21, 2346 4 of 22 Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 4 of 22 activation induces autophagy but determines that cancer cells preferentially enter senescence instead activation of apoptosisinduces [39]. autophagy but determines that cancer cells preferentially enter senescence instead of apoptosis [39]. In the intrinsic pathway, JNK-mediated phosphorylation of 14-3-3 protein, a cytoplasmic In the anchor of intrinsic pathway,induces several proteins, JNK-mediated phosphorylationXofprotein) Bax (Bcl-2-associated 14-3-3 protein, release aandcytoplasmic anchor translocation to of theseveral proteins, mitochondria induces [40], and the Bax (Bcl-2-associated release X protein) of the pro-apoptotic release proteins Badand translocation to (Bcl-2-antagonist of the cell mitochondria death) and FOXO3a[40], and[41]. the release JNK and of the p38pro-apoptotic proteins Bad (Bcl-2-antagonist can directly phosphorylate and regulate the of function cell death) of and FOXO3a several members [41].ofJNK and protein the Bcl-2 p38 canfamily. directlyJNKphosphorylate can induce the and regulate the function phosphorylation of Bad atofSer128 several to members of the Bcl-2 protein family. JNK can induce the phosphorylation of promote the apoptotic effect of Bad [42]. p38 and JNK induce Bax phosphorylation and mitochondrialBad at Ser128 to promote the apoptotic to translocation effect of Bad promote [42]. p38 apoptosis andThe [43]. JNK induce Bax activity pro-apoptotic phosphorylation and mitochondrial of Bim (Bcl-2-like protein 11) translocation depends on the tophosphorylation promote apoptosis [43].catalyzed at Ser65 The pro-apoptotic by JNK [44]activity of Bim[45]. or p38 MAPK (Bcl-2-like protein 11) During UV-induced depends apoptosis,on theand Bim phosphorylation at Ser65 Bmf (Bcl-2-modifying catalyzed factor), normallyby JNK [44] or by sequestered p38dynein MAPK and[45]. During myosin UV- V motor induced apoptosis, Bim and Bmf (Bcl-2-modifying factor), normally sequestered complexes, are released by JNK-dependent phosphorylation [46]. Bim and Bmf are BH3-only proteins by dynein and myosin V motor that interact withcomplexes, are released Bcl-2-like molecules by JNK-dependent to neutralize phosphorylation their anti-apoptotic effect. [46]. Bim and Bmf are BH3-only proteins that interact with Bcl-2-like molecules to neutralize Additionally, JNK and p38 may inhibit the functions of the anti-apoptotic their anti-apoptotic Bcl-2 familyeffect. members. It hasAdditionally, been shown JNK and p38 that JNK can may inhibit the Bcl-2 phosphorylate functions of the [47,48] andanti-apoptotic Mcl-1 (myeloid Bcl-2 cellfamily leukemia members. 1) [49], It has been shown that JNK can phosphorylate Bcl-2 [47,48] and Mcl-1 (myeloid thereby suppressing their anti-apoptotic function. In Fas-induced cell death, p38 activation attenuatescell leukemia 1) [49], thereby suppressing their anti-apoptotic function. In Fas-induced cell death, p38 the accumulation of the anti-apoptotic proteins Bcl-xL (B-cell lymphoma-extra large) and Bcl-2 in the activation attenuates the accumulation mitochondria of Figure [50]. the anti-apoptotic 1 summarizes proteins Bcl-xL all the known (B-cell JNKlymphoma-extra large) and substrates that promote Bcl-2 in thec cytochrome mitochondria [50]. Figure release from the mitochondria. 1 summarizes all the known JNK substrates that promote cytochrome c release from the mitochondria. Mcl-1 Bad Bcl-2 Bax JNK 14-3-3 Bmf Bim Protease-X iTCH c-FLIP jBid Casp-8 tBid Figure 1. JNK (C-Jun N-terminal kinase) substrates that regulate the mitochondrial apoptotic pathway. Figure 1. JNK (C-Jun N-terminal kinase) substrates that regulate the mitochondrial apoptotic JNK can have pro-apoptotic effects through direct phosphorylation of Bcl-2 (B-cell lymphoma 2) family pathway. JNK can have pro-apoptotic effects through direct phosphorylation of Bcl-2 (B-cell members. The phosphorylation of Bax (Bcl-2-associated X protein) will activate the pro-apoptotic lymphoma 2) family members. The phosphorylation of Bax (Bcl-2-associated X protein) will activate activity of this protein, whereas the phosphorylation of Bcl-2 and Mcl-1 (myeloid cell leukemia 1) the pro-apoptotic activity of this protein, whereas the phosphorylation of Bcl-2 and Mcl-1 (myeloid will suppress their anti-apoptotic function. Indeed, the direct phosphorylation and activation of cell leukemia 1) will suppress their anti-apoptotic function. Indeed, the direct phosphorylation and Bad (Bcl-2-antagonist of cell death), Bim (Bcl-2-like protein 11), or Bmf (Bcl-2-modifying factor) will activation of Bad (Bcl-2-antagonist of cell death), Bim (Bcl-2-like protein 11), or Bmf (Bcl-2-modifying inhibit the antiapoptotic effect of Bcl-2. In addition, JNK phosphorylation of 14-3-3 protein induces the factor) will inhibit the antiapoptotic effect of Bcl-2. In addition, JNK phosphorylation of 14-3-3 protein release of pro-apoptotic proteins Bax and Bad. JNK phosphorylation of the E3 ubiquitin ligase iTCH induces the release of pro-apoptotic proteins Bax and Bad. JNK phosphorylation of the E3 ubiquitin (itchy homolog) promotes the degradation of caspase-8 inhibitor c-FLIP (cellular FLICE (FADD-like ligase iTCH (itchy homolog) promotes the degradation of caspase-8 inhibitor c-FLIP (cellular FLICE IL-1β converting enzyme) inhibitory protein), therefore promoting caspase-8 activation and Bid (BH3 (FADD-like IL-1β converting interacting-domain enzyme) death agonist) inhibitory proteolysis protein), (tBid). JNK, therefore activated promoting caspase-8 by TNFα (tumor activation necrosis factor and alfa),Bid (BH3 also interacting-domain promotes death apoptosis through agonist) proteolysis proteolysis of Bid (jBid)(tBid). by anJNK, activated unknown by TNFα protease (tumor (X). All these necrosis factorinalfa), modifications also family the Bcl-2 promotes apoptosis members inducethrough proteolysis the release of Bid c(jBid) of cytochrome bySmac/DIABLO and/or an unknown protease (X). All these modifications (second mitochondria-derived in of activator the Bcl-2 family members caspases/direct induce inhibitor of the release apoptosis of cytochrome protein-binding proteinc and/or Smac/DIABLO (second mitochondria-derived activator of caspases/direct with low pI) from the mitochondria and subsequent caspase activation. Symbols used: activation (→), inhibitor of apoptosis inhibition protein-binding (—•). Pro-apoptoticprotein with of members low thepI) from Bcl-2 the are family mitochondria represented and subsequent in red caspase and anti-apoptotic activation. blue. used: activation (→), inhibition (―•). Pro-apoptotic members of the Bcl-2 family members inSymbols are represented in red and anti-apoptotic members in blue. Int. J. Mol. Sci. 2020, 21, 2346 5 of 22 3. JNK and p38 MAPK Cascades Also Mediate Anti-Apoptotic Processes JNK and p38 MAPK cascades not only promote pro-apoptotic processes; they are involved in anti-apoptotic mechanisms as well. There are many examples of anti-apoptotic processes mediated by transcriptional regulation. BNIP3 upregulation, through activation of the ERK and JNK pathways, is required for the protection of keratinocytes from UVB-induced apoptosis [51]. JNK activation attenuates endoplasmic reticulum (ER)-induced cell death due to enhanced expression of several anti-apoptotic proteins [52]. ER stress induced by thapsigargin and tunicamycin leads to increased expression of TRPV6 (transient receptor potential vanilloid channel 6) via the JNK signaling pathway, which could protect human embryonic stem cell-derived cardiomyocytes (hESC-CMs) from apoptotic cell death [53]. Besides, the JNK/c-Jun signaling pathway promotes annexin A2 overexpression that would suppress the expression of p53, and thus would decrease p53-regulated apoptotic genes [54]. In oxidized low-density lipoprotein (oxLDL)-induced macrophage apoptosis, p38 MAPK signaling pathway activation induces orphan nuclear receptor Nur77 expression that enhances cell survival via the suppression of apoptosis [55]. At post-translational levels, it was well established that phosphorylation of caspase-9 at Thr125 by ERK1/2 restrains intrinsic apoptosis in mitosis [56]. However, during the acute response to hyperosmotic stress in mouse embryonic fibroblasts, the inhibitory phosphorylation is catalyzed by p38 MAPK instead of ERK1/2 [57]. It was also reported that transient activation of JNK delays caspase-9 activation by direct interaction of JNK with Apaf 1 and cytochrome c to inhibit the apoptosome complex [58]. Another example of JNK’s anti-apoptotic function is the phosphorylation of Bad at Thr201 that promotes dissociation of the anti-apoptotic protein Bcl-xL from Bad [59]. It was reported recently that p38 MAPK/MK2 interacts with RIPK1 in a cytoplasmic complex and MK2 phosphorylates RIPK1 at Ser321/336 in response to pro-inflammatory stimuli and pathogens, which results in the inhibition of RIPK1 auto-phosphorylation and thus curtails RIPK1-dependent apoptosis and necroptosis [60]. Therefore, as we have seen in the previous sections, the activation of JNK and p38 signaling pathways can induce or prevent apoptosis. In Section 6, we will present an easy guide to understand the MAPK signaling function. 4. MAPK Signal Cross-Talks: JNK and p38 Do Not Always Work in Tune It could seem that JNK and p38 always work in tune, but things are more complicated. Crosstalk signaling between JNK and p38 MAPK is emerging as an important regulatory mechanism in stress responses. The JNK and p38 MAPK pathways share several upstream regulators, and accordingly there are multiple stimuli that simultaneously activate both pathways; however, there is evidence indicating that the p38 MAPK pathway can negatively regulate JNK activity in several contexts. Chemical inhibition of p38 strongly increased the activation of JNK [61], and deletion of the p38α gene induced JNK activation in a mouse model [62]. Wada et al. reported that the balance between JNK and p38 signaling pathways determines cell fate and links environmental and developmental stress to cell cycle arrest, senescence, oncogenic transformation, and adult tissue regeneration [63]. These authors also showed that antagonistic regulation of Cdc2 by JNK and p38 may be one of the checkpoints by which different stress-signaling pathways control the cell fate. Staples et al. demonstrated that UV-C-induced p38 activation increases the levels of MAPK phosphatase-1 (DUSP1) in mouse embryonic fibroblasts (MEFs), and DUSP1 protects these cells from UV-C-induced apoptosis by inactivating JNK [64]. More recently, by analyzing the single cell response to UV stress, it has been reported that p38-induced DUSP1 is inversely correlated with JNK activity, and this cross-inhibition generates cellular heterogeneity in JNK activity [65]. Although p38 causes variation of the DUSP1 protein levels between cells, the molecular mechanism is not so clear (see the concluding remarks). Anyway, cells are sentenced to death when JNK activity surpasses a threshold level [65]. Int. J. Mol. Sci. 2020, 21, 2346 6 of 22 5. The Two Faces of ERK in Apoptosis ERK1/2 activation is widely associated with anti-apoptotic functions by controlling cell proliferation and differentiation [11,66]. ERK can be anti-apoptotic by the downregulation of pro-apoptotic proteins and upregulation of anti-apoptotic proteins through both transcriptional and post-translational mechanisms (reviewed in [67]). However, there are several examples showing that ERK1/2 signaling can be pro-apoptotic (reviewed in [68]). Both cell cycle arrest and cell cycle re-enter can induce apoptosis. Aspafilioside B induces G2 phase cell cycle arrest and apoptosis through ROS-independent ERK and p38 MAPK activation [69]. It has been reported that both the G2 phase delay and blocked exit from the G2 checkpoint arrest are mediated by the MEK1-dependent destabilization of the critical G2/M regulator Cdc25B [70]. Postmitotic neurons, arrested in the G0 state, make attempts to re-enter the cell cycle in response to stress signals, which results in cell death. For example, it has been reported that β-amyloid peptide induces increased expression of cyclin D1 mediated by MEK-ERK activation, therefore promoting S-phase entry and neuronal cell death [71]. Different insults can induce apoptosis through activation of the ERK signaling pathway. DNA damage induced by cisplatin activates ERK1/2 and increases p53 protein levels [72]. The authors also found that ERK1/2 interacts with p53 and induces the phosphorylation of p53 at Ser15. Therefore, upregulation of p53 by the ERK signaling pathway may be one of the mechanisms of DNA damage-induced apoptosis. Activation of ERK1/2, JNK, and p38 MAPK with different kinetics were detected in perfluorohexanesulfonate (PFHxS)-induced neurotoxicity of PC12 cells. The ERK inhibitor significantly reduced apoptosis, while JNK inhibition significantly increased apoptosis, whereas the p38 MAPK inhibitor had no effect [73]. ERK1/2 activation also contributes to the anti-proliferation and apoptotic effects of NSC 95397 (a quinone-based small molecule compound) in colon cancer cells [74]. Glutamate-induced oxidative toxicity in neurons is associated with persistent ERK activation, and ERK inhibition protects cells from glutamate toxicity [75]. Combined TNFα and NMDA (N-methyl-d-aspartate) stimulation induces ERK signaling and cell death in mouse cortical neurons, which can be protected with MEK/ERK inhibition [76]. However, care should be taken when the conclusions are based, exclusively, on the effects of chemical inhibitors. Recently, it has been reported that ERK can facilitate apoptosis in response to oxidative stress and oxygen-glucose deprivation through phosphorylation of the pro-fusion protein mitofusin (MFN) 1, as phosphorylated MFN1 has a high affinity to the pro-apoptotic Bcl-2 family member Bak (Bcl-2 homologous antagonist killer) [77]. 6. An Easy Guide to Understand MAPKs-Regulated Apoptosis Taking into account the diverse and contradictory effects of MAPKs on the regulation of apoptosis, can we present some simple rules to understand the behavior of MAPKs? Is it possible to predict whether a stress response that activates MAPKs would end up in cell death? In other words, can we say something insightful without recurring to the common mantra “MAPK function in apoptosis depends on the cell type and the stimuli”? Let’s try it. First, MAPKs must have signaling properties well suited for the processing and propagation of external or internal stimuli that, in the face of a noxious situation, will determine whether a cell will survive and repair the damage or will die by apoptosis. The kinetics and the intensity of the signaling pathway activated is going to be important, as well as the presence of signaling loops. Next, we are going to describe the basic properties of MAPKs that are decisive on whether to engage a cell death program, and the positive feedback loops implicated. 6.1. Basic Signaling Properties of MAPKs Functioning as cellular sensors and switches, MAPKs play a critical role in the regulation of cell fate decisions. Cellular sensors must have signaling properties well suited for the processing Int. J. Mol. Sci. 2020, 21, 2346 7 of 22 and propagation of stimuli that promote irreversible processes. Basically, these properties are: Int. (1) J.Ultrasensitivity, Mol. Sci. 2020, 21, x meaning FOR PEER REVIEW that a small 7 of 22a increase in stimulus produces a very large response after threshold is crossed; (2) hysteresis, a form of biochemical memory reflected in the sustained activation threshold is crossed; (2) hysteresis, a form of biochemical memory reflected in the sustained of MAPK when the stimulus has disappeared; and (3) digital response, meaning an all-or-none response activation of MAPK when the stimulus has disappeared; and (3) digital response, meaning an all-or- at a single cell level [78] (Figure 2). none response at a single cell level [78] (Figure 2). (A) Ultrasensitivity (B) Hysteresis Stimulus No stimulus MAPK activity MAPK activity Hysteresis No hysteresis Stimulus dose Time (C) Digital Response (D) Positive Feedback Loop Stimulus Stimulus Time MAPK activity Early gradual 0% 20% X Y 100% Late digital All-or-none MAPK activity Z Figure Figure 2.2. Basic Basicproperties properties of ofMAPKMAPK (mitogen-activated (mitogen-activated protein kinase) protein kinase)signaling pathways. signaling pathways.(A) (A) Ultrasensitivity: Ultrasensitivity: A small A small increaseincrease in the in the stimulus stimulus produces produces a very a very large large response response in MAPKinactivity. MAPK activity. Graphically, Graphically, this is illustrated this is illustrated with acurve, with a sigmoid sigmoid curve,aimplying implying thresholdalevelthreshold for MAPKlevel activation. for MAPK activation. Several Several mechanisms biochemical biochemical can mechanisms explain this can explain (B) behavior. thisHysteresis: behavior. MAPKs (B) Hysteresis: MAPKs in front of a certain in front of a certain stimulus, and under certain conditions, present sustained stimulus, and under certain conditions, present sustained activation even when the stimulus has activation even when the stimulus hasbut disappeared disappeared but under under different different conditions orconditions or stimulus, stimulus, could return could to basal return to (no levels basal levels (no hysteresis). hysteresis). (C) Digital (C) Digital response: response: single cells single cells exposed exposed to a certain to a certain dose dose of stimulus of stimulus willwill presentan present aninitial initial homogeneous activation homogeneous activation of of MAPK MAPK (20% (20%activity, activity, graded graded response), response), which which could could be be converted converted intointo an an all-or-none response (0% or 100% activity, digital all-or-none response (0% or 100% activity, digital response) at response) at a later time. The generation of The generation of digital digital responses in responses in stress stress sensors sensors depends depends on on time, time, threshold threshold levels levels of of activation, activation, ultrasensitivity, ultrasensitivity, andand thethe presence of presence of positive positive feedback feedback loops. loops. (D) (D) Positive Positive feedback-loop: feedback-loop:An Aninitial initialstimulus stimuluswillwillactivate activateX, X, which in which in turn turnwill willactivate activateY,Y, which which will feed will back feed to the back to input X. These the input loops,loops, X. These that once thatengaged would once engaged be independent would of the initial be independent of the stimulus, are commonplace initial stimulus, are commonplacein irreversible biological in irreversible processes. biological processes. Ultrasensitive responses Ultrasensitive responses are are commonplace commonplace in in many many biological biological processes. processes. AtAtleast leastfour four different different mechanisms can generate ultrasensitive responses. These include zero-order ultrasensitivity, mechanisms can generate ultrasensitive responses. These include zero-order ultrasensitivity, multisite ultrasensitivity, multisite inhibitor inhibitor ultrasensitivity, ultrasensitivity, and positive ultrasensitivity, andfeedback loops [79,80]. positive feedback loopsPositive [79,80]. and negative Positive and feedback loops are also common regulatory elements in biological signaling systems. negative feedback loops are also common regulatory elements in biological signaling systems. Positive feedback is defined Positive as a setisofdefined feedback regulatory as a steps set of that feeds the regulatory output steps signalthe that feeds back to thesignal output inputback [81] to (Figure 2D). the input Ultrasensitive [81] (Figure 2D). systems embedded Ultrasensitive in a positive systems embeddedfeedback loop have in a positive the potential feedback loop have to the exhibit bistable potential to behavior, switching between discrete stable steady states without being able to rest in exhibit bistable behavior, switching between discrete stable steady states without being able to rest intermediate states in [82–84]. The intermediate three states hallmarks [82–84]. of a bistable The three system hallmarks of a are strong bistable ultrasensitivity, system are strong digital response ultrasensitivity, at the response digital individual at cell level, and cell the individual hysteresis. level, andExamples ofExamples hysteresis. such systems aresystems of such the response are theof JNK to response of JNK to hyperosmotic shock, and the response of ERK to progesterone, which were described by the elegant works of James E. Ferrell in Xenopus oocytes, a suitable cell model to study these properties [85,86]. We also reported the basic properties of the p38 signaling pathway in response to Int. J. Mol. Sci. 2020, 21, 2346 8 of 22 hyperosmotic shock, and the response of ERK to progesterone, which were described by the elegant works of James E. Ferrell in Xenopus oocytes, a suitable cell model to study these properties [85,86]. We also reported the basic properties of the p38 signaling pathway in response to hyperosmotic shock by using Xenopus oocytes. The response of p38 to osmostress was ultrasensitive, bimodal, and with low hysteresis [87]. In mammalian cells, JNK signaling also showed ultrasensitivity in response to different stimuli, and a switch-like response at a single cell level but no hysteresis [88]. It is also interesting to note that in mammalian cells, ERK activation by PDGF (platelet-derived growth factor) was not ultrasensitive, and showed a graded response at a single cell level, but the graded activation of ERK was converted into a more switch-like behavior (digital response) downstream of the kinase cascade, at the level of immediate–early gene induction [89]. The authors also found that, whereas ERK activation was graded, ERK localization into the nucleus presented an all-or-none (digital) behavior, suggesting that an unknown mechanism that controls nuclear translocation and/or retention of ERK is likely responsible for the ultrasensitive responses downstream. In Saccharomyces, it has been described that Hog1 (high osmolarity glycerol 1), the homologous of p38, gradually accumulates in the nucleus after increasing the salt concentration, but the transcriptional output obtained is bimodal [90]. Since switch-like responses obtained at a single cell level are common in MAPKs and other protein kinases, we proposed a digital model for cell decisions. Using the analogy of cells as information devices and of protein kinases as transistors or chips in computers, we can imagine networks of kinases that generate digital information to “run” different programs (like the cell death program). Therefore, a general model for sensing, integrating, and making choices, based in the generation of digital responses, may be applied to different biological processes [78]. 6.2. Strong Versus Weak and Sustained Versus Transient Signaling The ultrasensitive properties of MAPKs and the existence of threshold levels for the activation of downstream targets can explain the digital outputs obtained after MAPK activation. We observed that the response of JNK to hyperosmolar sorbitol is switch-like in character, and that an initial graded response is converted into digital after the critical period of cytochrome c release [91]. As we will see later, there are multiple feedback loops that might contribute to the digital response observed. Two important factors that regulate apoptosis are the strength and the duration of the signal. It is well known that the pro- or anti-apoptotic effects of MAPK activation depend on the duration of the signal. For instance, transient JNK activation is shown to promote cell survival, whereas prolonged JNK activation induces apoptosis [92]. The duration of phosphorylation of p38 also seems crucial to regulate cell fate, since sustained activation is associated with apoptosis [93], whereas transient phosphorylation is associated with survival [94]. For example, in SKT6 cells exposed to osmotic or heat shock, transient activation of JNK and p38 MAPK promotes erythroid differentiation, whereas prolonged activation of JNK and p38 MAPK causes apoptosis [95]. In yeast, sustained activation of p38 (Hog1) results in a severe growth defect and cell death by promoting high levels of reactive oxygen species (ROS) [96]. Persistent activation of ERK1/2 promotes glutamate-induced oxidative toxicity in neuronal cells [75]. It has been proposed that the main cause of sustained ERK activation is the presence of ROS during the cell death program [68]. However, sustained activation of ERK signaling is not only involved in apoptosis but also in cell cycle progression, cellular transformation, and differentiation [97]. Although it is generally accepted that strength and long signal duration are relevant to engaging apoptosis, this is not well explained at a molecular level. How are different targets that regulate cytochrome c release and caspase activation sensitive to the kinetics and strength of MAPK signaling? We propose that strong MAPK activation (mainly JNK and p38) might be enough to surpass a threshold level that would activate specific pro-apoptotic targets. Similarly, sustained activation of MAPKs could activate additional targets that are not usually activated by transient signaling. The affinity of the targets for activated MAPKs could be an important factor to determine which targets are activated first Int. J. Mol. Sci. 2020, 21, 2346 9 of 22 (anti-apoptotic) and which are activated later (pro-apoptotic). In other words, the pro-apoptotic targets would have low affinity for MAPKs, but they could be activated when MAPK activity is high and/or sustained, meaning that an increased amount of activated MAPK can interact with additional targets. For example, it has been reported that an increasing concentration of constitutively active MKK6 differentially activates either p38α alone (low MKK6 activity) or both p38α and p38γ (high MKK6 activity), both in vitro and in injected oocytes [98]. Interestingly, it has been shown that the temporal ordering of cell cycle phosphorylation depends on intrinsic properties of the substrate proteins: Good kinase substrates tend to be phosphorylated early, and good phosphatase substrates tend to be phosphorylated late [99–101]. 6.3. Feedback Loops Could Explain Complex Biological Processes Douglas R. Hofstadter, in his insightful book “I Am a Strange Loop” published in 2007 [102], proposed that consciousness could arise in the brain as a consequence of intricate interactions between symbols, which are not yet well defined at a molecular level but could be represented as clusters of activated neurons. Hofstadter also proposed that the presence of multiple feedback loops in this complex interactive network of symbols might be responsible for the sense of “I” or consciousness in evolved brains. At first sight, feedback loops could seem strange, or even dangerous, for most people as Hofstadter points out, but scientists are more familiar with them. Feedback control is widespread in different biological systems and is very important to regulate intercellular signaling during development (reviewed in [103]). Feedback loops are also common in intracellular signaling to modulate cell responses in space and time and to control cell fate [81]. Negative feedback loops are well known in cellular systems and are necessary to maintain homeostasis. The first demonstration of an end-product feedback inhibition of a biosynthetic pathway (cholesterol homeostasis) was due to Rudolph Shoenheimer in 1933 [104]; a more recent example applies to the negative feedback loops that control iron homeostasis [105]. Negative feedback loops can also produce oscillations [84,106]. Indeed, many examples of positive feedback loops have been reported, and these loops can amplify a signal, change the timing of a signaling response, and create bistable switches [84,106,107]. As we will see next, these positive feedback loops are fundamental to explaining the irreversibility of the apoptotic process. 6.4. How Cells Die through Positive Feedback Loops The ultrasensitive response and the sustained activation of MAPKs, when the stimulus has disappeared, could be a consequence of the engagement of positive feedback loops when a threshold is reached. During the cell death program, multiple positive feedback loops have been reported (Figure 3). Cytochrome c release from the mitochondria induces caspase-9 and subsequent caspase-3 activation, which in turn produces Bcl-2 proteolysis, thus promoting more cytochrome c release and caspase-9/-3 activation in a positive feedback loop [108]. Bid proteolysis by caspase-8 produces tBid, which induces cytochrome c release, caspase-9, and caspase-6 activation, which in turn promotes proteolysis and activation of caspase-8, closing the vicious loop [109]. A similar loop has been reported by proteolysis of Bid induced by caspase-3 [110,111]. Caspase-3 also induces direct proteolysis and full activation of caspase-9 and was considered a positive feedback loop [112]. However, Denault et al. found that dimerization of caspase-9 within the apoptosome complex (leading to its autocatalytic cleavage) is required for subsequent cleavage by caspase-3, thus releasing the inhibitory effect of XIAP (X-linked inhibitor of apoptosis protein) on caspase-9 [113]. These authors refer to this mechanism as derepression instead of feedback activation [113], although this is a moot point [114]. Pro-caspase-3 is also a substrate of caspase-8 [115], making the caspase activation network more complex (Figure 3A). Recently, a systematic analysis of the individual and combined roles of caspases in chemotherapy-induced cell death within human leukemic cell lines, using CRISPR-Cas9 gene targeting, has shown that the activation of effector caspase-3 or -7 produces feedback amplification and efficient apoptotic cell death Int. J. Mol. Sci. 2020, 21, 2346 10 of 22 by inducing full activation of apical caspases (caspase-8 and -9) [116]. This study emphasizes the important role of effector caspases in engaging positive feedback loops for efficient cell death. Very often, caspases are substrates of kinases and kinases are substrates of caspases in a death grip [117]. MEKK1 (MAPK/ERK kinase kinase 1), a MAPKKK that ultimately can activate JNK and p38 [118], is cleaved by caspase-3 during anoikis, Fas stimulation, and DNA damage [119–121]. The fragment obtained is a constitutively active MEKK1 that promotes cytochrome c release and caspase-9/-3 activation in turn (Figure 3A). In the JNK/p38 MAPK cascades, the second messenger reactive oxygen species (ROS) regulates MAPK activation in a positive circuit. It has been reported that ROS, generated by NADPH oxidase, activates JNK, which in turn activates NADPH oxidase in a positive feedback loop [122]. It has also been reported that the activation of NADPH oxidase 2 in cadmium-induced apoptosis activates JNK through ROS generation and protein phosphatase 5 (PP5) inactivation, and JNK activation in turn increases the expression of NADPH oxidase and its regulatory proteins (p22phox, p40phox, p47phox, p67phox, and Rac1), which promotes ROS generation, thus creating a positive feedback loop [123]. Shi et al. reported that ROS generation induces JNK activation, which in turn induces ROS generation through p53 activation [27]. A similar feedback loop between p53 activation, ROS generation, and p38 activation that in turn induces p53 activation was observed in cisplatin-induced apoptosis [124]. Sustained p38 activation induces important metabolic changes and enhances the respiration rate, thus increasing the production of mitochondrial ROS, which contributes to p38-induced apoptosis [125]. In isoliensinine-induced apoptosis of triple-negative breast cancer cells, the generation of ROS activates both the JNK and p38 MAPK signaling pathways, and p38 activation also induces ROS elevation in a positive feedback loop [126]. ASK1 (apoptosis signal-regulating kinase 1) is a MAP kinase kinase kinase (MAP3K) of JNK and p38 MAPK, which is preferentially activated by ROS (reviewed in [127]). Thus, ask1−/− embryonic fibroblasts are resistant to H2 O2 -induced apoptosis and sustained activation of JNK and p38 MAPK is lost [93]. Recently, it was reported that TNFR1 (tumor necrosis factor receptor 1) stimulated by ω-3-17,18-epoxyeicosanoic acid (C20E) activates the ASK1-MKK4/7-JNK/p38 MAPK signaling pathway, which results in Bid cleavage [128]. ASK1 is involved in different positive feedback loops. TNFα treatment induces the accumulation of Daxx (death-associated protein 6) protein by preventing its proteasome-dependent degradation in an ASK1-mediated pathway, and Daxx induces the activation of ASK1 [129]. In gastric cancer, ASK1 overexpression induces the transcription of cyclin D1 through AP-1 activation, and ASK1 levels are regulated by cyclin D1 in turn via the Rb-E2F (retinoblastoma-E2F transcription factor) pathway [130]. Besides ROS, ceramide is another second messenger associated with apoptosis. It has been reported that ceramide can initiate apoptosis through Rac1- or ASK1-regulated activation of the JNK/p38 MAPK cascades [131]. The JNK signaling pathway stimulates ceramide generation and promotes apoptosis by phosphorylation of neutral sphingomyelinase (nSMase) [132]. Therefore, a positive feedback loop exists between JNK activation and ceramide production. In summary, different positive feedback loops could promote sustained activation of the JNK/p38 signaling pathways (Figure 3B). Int. J. Mol. Sci. 2020, 21, 2346 11 of 22 Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 11 of 22 (A) (B) Caspase-9 NADPH oxidase 15 Caspase-6 11 Caspase-8 ROS Caspase-3 14 15 13 14 17 11 12 Daxx Bcl-2 MEKK1 Bid ASK1 Ceramide 12 13 p38 JNK nSMase p38 12 13 JNK p53 AP-1 16 Cytochrome c Cyclin D1 release Figure Figure 3. Positive feedback 3. Positive feedback loops loops in in apoptosis. apoptosis. (A)(A) Caspases, Caspases, kinases, kinases, and and Bcl-2 Bcl-2 family family members members are are functionally linked in positive feedback loops to induce cell death. (1) Cytochrome c release functionally linked in positive feedback loops to induce cell death. (1) Cytochrome c release from the from the mitochondria, mitochondria, aa meeting meeting point point inin the the cell cell death death pathways, pathways, induces induces caspase caspase activation. Caspase-9 and activation. Caspase-9 and subsequent subsequent caspase-3 activation produces Bcl-2 proteolysis, which in turn promotes more cytochromec caspase-3 activation produces Bcl-2 proteolysis, which in turn promotes more cytochrome release c release[108]. [108].(2) (2)Caspase-3 Caspase-3induces inducesproteolysis proteolysisand andconstitutive constitutive activation activation of of MEKK1 MEKK1 (MAPK/ERK (MAPK/ERK kinase kinase kinase 1), that promotes cytochrome c release and caspase-9/-3 activation though kinase 1), that promotes cytochrome c release and caspase-9/-3 activation though JNK/p38 JNK/p38 activation activation [119–121]. [119–121].(3(3and Caspase-3 and4)4) Caspase-3 [110,111] or caspase-8 [110,111] [109][109] or caspase-8 induce Bid proteolysis induce (tBid), (tBid), Bid proteolysis which in turn promotes cytochrome c release and caspase activation. (5) Caspase-3 is activated by caspase-9, which in turn promotes cytochrome c release and caspase activation. (5) Caspase-3 is activated by which in turn can induce proteolysis and full activation of caspase-9 [112,113]. (B) ROS (reactive caspase-9, which in turn can induce proteolysis and full activation of caspase-9 [112,113]. (B) ROS oxygen species) generation and ASK1 (apoptosis signal-regulating kinase 1) activation are sustained by (reactive oxygen species) generation and ASK1 (apoptosis signal-regulating kinase 1) activation are multiple positive feedback loops. (1) NADPH oxidase generates ROS and activates ASK1 and JNK, sustained by multiple positive feedback loops. (1) NADPH oxidase generates ROS and activates ASK1 which in turn activates NADPH oxidase [122,123]. (2 and 3) JNK and/or p38 activation, induced by and JNK, which in turn activates NADPH oxidase [122,123]. (2 and 3) JNK and/or p38 activation, ROS, produces p53 activation, which in turn induces ROS generation [27,124]. (4) Sustained activation induced by ROS, produces p53 activation, which in turn induces ROS generation [27,124]. (4) of p38 increases ROS production, which in turn activates ASK1 and p38 [125,126]. (5) ASK1 activation Sustained activation of p38 increases ROS production, which in turn activates ASK1 and p38 [125,126]. induces the accumulation of Daxx protein, which in turn further activates ASK1 [129]. (6) ASK1 induces (5) ASK1 activation induces the accumulation of Daxx protein, which in turn further activates ASK1 transcription of cyclin D1 through AP-1 (activator protein 1) activation, which in turn increases ASK1 [129]. (6) ASK1 induces transcription of cyclin D1 through AP-1 (activator protein 1) activation, which levels via the Rb-E2F (retinoblastoma-E2F transcription factor) pathway [130]. (7) Ceramide activates in turn increases ASK1 levels via the Rb-E2F (retinoblastoma-E2F transcription factor) pathway [130]. the ASK1 and JNK signaling pathway, which in turn activates neutral sphingomyelinase (nSMase), (7) Ceramide activates the ASK1 and JNK signaling pathway, which in turn activates neutral thus increasing ceramide production [131,132]. The loops represented in the figure do not necessarily sphingomyelinase (nSMase), thus increasing ceramide production [131,132]. The loops represented take place in the same cell and at the same time. Some loops are activated by a specific stimulus or in a in the figure do not necessarily take place in the same cell and at the same time. Some loops are certain cell type. Symbols used: activation (→), inhibition (—•). activated by a specific stimulus or in a certain cell type. Symbols used: activation (→), inhibition (―•). 7. Xenopus Oocytes as a Cell Model to Understand Apoptosis 7. Xenopus Oocytes as a Cell Model to Understand Apoptosis Xenopus oocytes are a very useful system to study cell death mechanisms. The cell-free system Xenopus based on Xenopusoocytes eggare a very extracts useful was usedsystem to study cell in the pioneering death mechanisms. experiments describing The thecell-free system mitochondrial based on Xenopus apoptotic pathwayegg andextracts was the role of used in the pioneering cytochrome c release inexperiments describing caspase activation the mitochondrial [133,134]. Moreover, apoptotic pathway and the role of cytochrome c release in caspase activation [133,134]. Xenopus oocytes can be used as an in vivo system since these cells, when submitted to different stresses, Moreover, Xenopusthe initiate oocytes can be used mitochondrial as an pathway in vivo system of apoptosis. since of Expression these cells,[135], Bcl-x(S) when submitted oocyte nutrientto depletion different stresses, through induced initiate the mitochondrial inhibition pathway of the pentose of apoptosis. phosphate Expression pathway of Bcl-x(S) [136], neutral [135], oocyte nutrient sphingomyelinase-induced depletion[137], ceramide induced through shock or hyperosmotic inhibition of the apoptosis [91] promotes pentose inphosphate pathway Xenopus oocytes. These[136], neutral cells might be sphingomyelinase-induced appropriate ceramideregulation for the study of metabolic [137], or ofhyperosmotic cancer since theshock oocytes[91]exhibit promotes alteredapoptosis metabolismin Xenopus oocytes. These cells might be appropriate for the study of metabolic regulation of cancer since the oocytes exhibit altered metabolism coupled to its apoptotic machinery in a similar fashion Int. J. Mol. Sci. 2020, 21, 2346 12 of 22 coupled to its apoptotic machinery in a similar fashion to cancer cells [138]. Besides environmental stimuli, the apoptotic machinery can be turned on spontaneously during meiotic maturation in unfertilized Xenopus eggs [139]. Xenopus oocytes allow greater manipulation than other systems and are especially suitable for biochemical determinations at a single cell level. For instance, it is possible to measure by Western blot the activation of MAPKs and the release of cytochrome c in single cells. Capped RNAs are microinjected in the oocytes to express, with high efficiency, the constitutively active or dominant negative mutants of the protein kinases. It is also possible to microinject antibodies, antisense oligonucleotides, or other molecules that cannot cross the cell membrane in order to manipulate any specific signaling pathway. Importantly, cytochrome c microinjection in Xenopus oocytes induces caspase-3 activity [140], making affordable the study of the signaling pathways activated by cythochrome c release and the positive feedback loops engaged by caspases [87,111]. Recently, by using Xenopus oocytes and egg extracts, it was demonstrated that positive feedback loops allow apoptosis to spread though the cytoplasm in self-regenerating trigger waves, which were correlated with caspase activation [141]. 8. MAPK Dynamics in Hyperosmotic Shock-Induced Apoptosis Hyperosmolarity has many damaging effects on cells by promoting water flux out of the cell, triggering cell shrinkage and intracellular dehydration [142]. Cells have developed survival mechanisms to adapt osmotic changes [143], but when the stress is intense or persistent, it triggers apoptosis [144–148]. During the last years, we analyzed the mechanisms that regulate osmostress-induced apoptosis in Xenopus oocytes. We reported that hyperosmotic stress induces cytochrome c release and caspase-3 activation [91]. We have also described the time-course events during the apoptotic program and the role of stress protein kinases, calpains, and Smac/DIABLO. Hyperosmotic shock induces rapid calpain activation and high levels of Smac/DIABLO release from the mitochondria (early events) before significant amounts of cytochrome c are released to promote caspase-3 activation (late events) [149]. Hyperosmotic shock also activates the p38 and JNK signaling pathways very quickly [87,91]. Simultaneous inhibition of both p38 and JNK pathways reduces osmostress-induced apoptosis, while sustained activation of these kinases accelerates the release of cytochrome c and caspase-3 activation. Therefore, at least four different pathways induced early by osmostress converge on the mitochondria to trigger apoptosis [149]. Recently, we characterized the JNK isoforms activated by hyperosmotic shock and their role in apoptosis. Transcripts derived from the jnk1 gene present alternative splicing at the C terminus, yielding short and long JNK1 variants (JNK1-1 and JNK1-2, respectively). We have shown that JNK1-1 and JNK1-2 are activated early by osmostress and that sustained activation of both isoforms accelerates the apoptotic program. Later, when caspase-3 is activated, JNK1-2 is proteolyzed at Asp385, increasing the release of cytochrome c and caspase-3 activity, and therefore creating a positive feedback loop [111]. Since cleaved JNK1-2 and JNK1-1 have similar amino acid sequences except for the last five at the C-terminal, and the expression of the short JNK1-2 fragment has a clear apoptotic effect compared with JNK1-1, it implies that the last amino acids of the JNK1-2 fragment might be important for regulating cytochrome c release and caspase-3 activation in the positive feedback loop engaged after JNK1-2 cleavage [111]. In addition, an unknown protease induces early proteolysis of Bid and mono-ubiquitinated Bid at Asp52, which in turn increases the release of cytochrome c and caspase-3 activity, which in turn produces massive proteolysis of Bid, thus creating a second positive feedback loop [111]. Interestingly, we have also reported that cytochrome c microinjection in Xenopus oocytes induces phosphorylation of p38 through caspase-3 activation, and caspase inhibition reduces the level of p38 activation induced by osmostress, suggesting that a third positive feedback loop is engaged by hyperosmotic shock [87]. In addition, it has been reported that caspases can induce proteolysis of the calpain inhibitor calpastatin [150,151], thus increasing calpain activation in a positive loop. In summary, Int. J. Mol. Sci. 2020, 21, 2346 13 of 22 hyperosmotic shock induces the activation of different pathways that converge on the activation of caspase-3, which engages an irreversible apoptotic program through the activation of multiple positive Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 13 of 22 feedback loops. A model for activation osmostress-induced of caspase-3, which engages apoptosis in Xenopus an irreversible oocytes apoptotic is presented program through inthe Figure 4. Theofmodel activation is composed of two different multiple positive feedback loops. phases: A reversible and an irreversible phase. In the reversible A model for osmostress-induced phase, anti-apoptotic apoptosis in and pro-apoptotic responses Xenopus occur oocytes is presented synchronically, includinginthe Figure rapid4. release The of model is composed Smac/DIABLO, calpainofactivation, two different phases: early Bid A reversibleand cleavage, andJNK/p38 an irreversible MAPK phase. In the reversibleThese phosphorylation. phase,are pathways anti-apoptotic and pro-apoptotic going to converge responses occur on the mitochondria synchronically, to trigger caspase-3including the rapid activation. release Oocytes are not of Smac/DIABLO, calpain activation, early Bid cleavage, and JNK/p38 MAPK phosphorylation. These committed to death in the reversible phase and could recover when the stress is removed. MAPKs pathways are going to converge on the mitochondria to trigger caspase-3 activation. Oocytes are not (JNK and p38) are sensors of stress that would activate early anti-apoptotic substrates (A, B, C), but committed to death in the reversible phase and could recover when the stress is removed. MAPKs strong (JNKand/or sustained and p38) activation are sensors of stressofthat MAPKs wouldwould activateactivate late pro-apoptotic early anti-apoptotic substrates substrates (X, Y, Z). (A, B, C), but These substrates, not yet characterized, could include different Bcl-2 family members. strong and/or sustained activation of MAPKs would activate late pro-apoptotic substrates (X, Y, Z). Mitochondria integrate Thesethe available substrates, notinformation to regulate yet characterized, could cytochrome c release, include different which, Bcl-2 family after reaching members. a threshold Mitochondria levelintegrate in the cytosol, activates the available caspase-3 information that engages to regulate multiple cytochrome positive c release, which,feedback loopsa threshold after reaching to produce an level in the irreversible death.cytosol, activates caspase-3 that engages multiple positive feedback loops to produce an irreversible death. Choreography of Osmostress-induced Apoptosis Xenopus oocytes Time SENSING Bid 0 Substrates ADAPTATIVE Smac/DIABLO proteolysis JNK 1-1 p38 A,B,C CALPAINS JNK 1-2 (early) SURVIVING 5 min Protein Kinases (% Activity) 1h 100 INTEGRATION OF RESPONSES Substrates X,Y,Z 2h POSITIVE 3h Cytochrome c FEEDBACK LOOPS Apoptosome CALPAINS JNK 1-2 4h proteolyzed DEATH Caspase-3 Bid proteolysis (late) p38 Figure Figure 4. A4.model A modelforfor osmostress-induced apoptosis. osmostress-induced apoptosis. InInXenopus Xenopusoocytes, hyperosmotic oocytes, hyperosmoticshockshock inducesinduces rapid calpain activation, Smac/DIABLO release from the mitochondria, cleavage of small amounts of rapid calpain activation, Smac/DIABLO release from the mitochondria, cleavage of small amounts Bid by an unknown protease, and MAPK activation (JNK1-1, JNK1-2, and p38). Low amounts of of Bid by an unknown protease, and MAPK activation (JNK1-1, JNK1-2, and p38). Low amounts of cytochrome c are released from the mitochondria at this early stage (0–1 h), but they are not sufficient cytochrome c are released from the mitochondria at this early stage (0–1 h), but they are not sufficient to activate caspase-3. Stress protein kinases (JNKs and p38) would act as cellular sensors to evaluate to activate caspase-3. Stress the stressful situation. protein MAPKs can kinases engage, by(JNKs earlyand p38) would act phosphorylation as cellular of some sensors substrates (A, B,toC), evaluate a the stressful protective response. Mitochondria integrates the information received by stress sensors at this early B, C), situation. MAPKs can engage, by early phosphorylation of some substrates (A, a protective response. stage, where the cellMitochondria could recover integrates if the stressthe doesinformation received not persist or by stress gets weaker. sensors However, at this early sustained stage, where and the cell increased could of activation recover MAPKsifwillthe lead stress to does not persist or gets late phosphorylation weaker. However, and activation sustained of pro-apoptotic substrates (X, and increased Y, Z), including activation Bcl-2will of MAPKs family leadmembers. A marked release ofand to late phosphorylation cytochrome c will activation promote of pro-apoptotic caspase-3 substrates (X, activation (2 h), which Y, Z), including Bcl-2infamily turn would members.induceA more markedcalpain activation, release cleavage of of cytochrome JNK1-2 c will promote and Bid, caspase-3 and p38(2activation. activation h), whichThese in turnevents would promote induceadditional cytochrome more calpain c release activation, and caspase-3 cleavage of JNK1-2 and activation in multiple positive feedback loops, resulting in an irreversible apoptotic process (2–4 h). Bid, and p38 activation. These events promote additional cytochrome c release and caspase-3 activation The blue color in the arrows represents early responses to stress in the reversible phase of apoptosis, in multiple positive feedback loops, resulting in an irreversible apoptotic process (2–4 h). The blue and the red color represents late responses in the irreversible phase. color in the arrows represents early responses to stress in the reversible phase of apoptosis, and the red color 9. representsRemarks Concluding late responses in the irreversible phase. Int. J. Mol. Sci. 2020, 21, 2346 14 of 22 9. Concluding Remarks MAPKs regulate apoptosis through transcriptional and post-transcriptional mechanisms. Although p38 and JNK activation are usually associated with pro-apoptotic effects and ERK activation with anti-apoptotic effects, examples of the opposite were also presented here. Moreover, MAPK signal crosstalk between JNK and p38 MAPK is an additional regulatory mechanism in stress responses. The dual role of MAPKs in cell death (pro- and anti-apoptotic) can be partially explained by the diversity of targets activated through different stimuli, or by the molecular context where a specific stimulus is acting (the cell type considered). However, even in a certain cell type exposed to a specific stimulus, the activation of a MAPK signaling pathway can be pro- and/or anti-apoptotic. This paradox can be explained, in part, by the basic properties of MAPK signaling systems. The ultrasensitive properties of MAPKs and the existence of threshold levels for activation explain why strong and/or sustained activation of MAPKs is pro-apoptotic, whereas weak and/or transient activation is anti-apoptotic. Further studies about the temporal ordering of phosphorylation, early for anti-apoptotic targets and late for pro-apoptotic targets, are necessary to better understand the behavior of MAPKs. It seems that the differential affinity of substrates for MAPKs could account for the kinetics and dual nature of MAPKs. A second paradox is why some cells submitted to the same dose of stimulus during the same time can survive, whereas others are committed to cell death. The signaling properties of MAPKs, including the presence of multiple positive feedback loops, explain why single cells exposed to intermediate levels of stress present all-or-none (digital) responses. However, the molecular reason for this heterogeneous response is not so clear. As we have pointed out before, it has been reported that UV stress generates cellular heterogeneity in JNK activity through variations in the protein levels of MAPK phosphatase-1 (DUSP1) via p38 activation [65]. However, it is unclear how the DUSP1 induction varies between cells. It has been proposed that the intrinsic noise of gene expression produces cellular heterogeneity that is known as non-genetic heterogeneity [152]. Interestingly, it has been shown that cells present a heterogeneous composition in pro- and anti-apoptotic factors, which are the primary causes of cell-to-cell variability in the timing and probability of death in TRAIL (TNF-related apoptosis-inducing ligand)-induced apoptosis [153]. It is likely that a multivariate control due to different proteins and signaling pathways, including MAPKs, is operating in most types of cell death. Therefore, the prediction of the fate of single cells exposed to stress might be difficult, but not impossible, since it would require integrating the information obtained from different factors. Here, we described the presence of multiple positive feedback loops in apoptosis. These loops are fundamental to the creation of self-sustained trigger waves of activity (caspases and/or kinases) in space and time. Figure 5 is a simplified version of the complex loops of signaling previously described. Such a modular structure could be a general mechanism to attain irreversible changes in the cell, and therefore might be applied to other biological processes, although the kinases and proteins involved could be different. For instance, the ERK signaling pathway is activated by progesterone in Xenopus oocytes and regulates meiotic progression through activation of the Cdc2/Cyclin B (MPF) complex, although JNK is not involved [154]. Several positive feedback loops have been described for this biological process that assure sustained activation of ERK2 and MPF to promote an irreversible maturation of the oocyte [155–158]. A review on MAPKs will always show a puzzling image. This is not surprising at all, since MAPKs are involved in multiple processes and cellular signaling is a complex world. However, here, we have tried to extract and distill some principles about MAPK signaling and function. Understanding MAPK signaling pathways gives us insight about how cells take decisions in front of stimuli. It is certainly a rewarding activity for a biologist. Int. J. Mol. Sci. 2020, 21, 2346 15 of 22 Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 15 of 22 Stress signal MAPKK JNK/p38 Cytochrome c release Caspases Figure 5. MAPKs in apoptosis: A simplified model. An input, represented by a stress signal (Ca2+2+, Figure 5. MAPKs in apoptosis: A simplified model. An input, represented by a stress signal (Ca , ROS, osmotic shock, death receptor, etc.), will activate a MAPK cascade, which in turn feedbacks on ROS, osmotic shock, death receptor, etc.), will activate a MAPK cascade, which in turn feedbacks on the initial input/cascade to achieve higher MAPK activation. After a threshold of MAPK activation is the initial input/cascade to achieve higher MAPK activation. After a threshold of MAPK activation is surpassed, additional downstream targets are activated, promoting cytochrome c release and caspase surpassed, additional downstream targets are activated, promoting cytochrome c release and caspase activation. Other positive feedback loops, engaged downstream of MAPKs, will keep sustained and activation. Other positive feedback loops, engaged downstream of MAPKs, will keep sustained and high levels of activation of JNK/p38 and caspases, assuring the irreversibility of the apoptotic process. high levels of activation of JNK/p38 and caspases, assuring the irreversibility of the apoptotic process. Author Contributions:J.Y. AuthorContributions: J.Y.and andJ.M.L. J.M.L.drafted draftedthe themanuscript. manuscript.All authors have read and agreed to the published version of the manuscript. Funding:This Funding: This work work was was supported supported byby Spanish Spanish Ministerio Ministerio de de Economía Economía yy Competitividad Competitividad Grant Grant BFU2010-15978. BFU2010-15978. ConflictsofofInterest: Conflicts Interest:The Theauthors authorsdeclare declareno noconflict conflictofofinterest. interest. References References 1.1. Ray,L.B.; Ray, L.B.;Sturgill, Sturgill,T.W. T.W.Rapid Rapidstimulation stimulationby byinsulin insulinofofaaserine/threonine serine/threoninekinase kinaseinin3T3-L1 3T3-L1adipocytes adipocytesthat that phosphorylates microtubule-associated protein 2 in vitro. Proc. Natl. Acad. Sci. USA phosphorylates microtubule-associated protein 2 in vitro. Proc. Natl. Acad. Sci. USA 1987, 84, 1502–1506. 1987, 84, 1502–1506. 2. Ray, L.B.; [PubMed] [CrossRef] Sturgill, T.W. Insulin-stimulated microtubule-associated protein kinase is phosphorylated on 2. tyrosine and threonine Ray, L.B.; Sturgill, T.W. in vivo. Proc. Natl. Acad. Insulin-stimulated Sci. USA 1988, 85, 3753–3757. microtubule-associated protein kinase is phosphorylated on 3. Boulton, T.G.; Yancopoulos, G.D.; Gregory, J.S.; Slaughter, tyrosine and threonine in vivo. Proc. Natl. Acad. Sci. USA 1988, C.; Moomaw, C.; Hsu, 85, 3753–3757. J.; Cobb, M.H. An insulin- [CrossRef] 3. Boulton, T.G.; Yancopoulos, G.D.; Gregory, J.S.; Slaughter, C.; Moomaw, C.; Hsu, J.;1990, stimulated protein kinase similar to yeast kinases involved in cell cycle control. Science Cobb,249,M.H. 64–67. An 4. Boulton, T.G.; Nye, insulin-stimulated S.H.; Robbins, protein D.J.; Ip, kinase similar N.Y.;kinases to yeast Radziejewska, involvedE.;inMorgenbesser, cell cycle control. S.D.; DePinho, Science 1990, R.A.; 249, Panayotatos, 64–67. N.; Cobb, [CrossRef] [PubMed]M.H.; Yancopoulos, G.D. ERKs: A family of protein-serine/threonine kinases that 4. are activated and tyrosine Boulton, T.G.; Nye, S.H.; Robbins,phosphorylated D.J.; Ip,inN.Y.; response to insulin and Radziejewska, NGF. Cell 1991,S.D.; E.; Morgenbesser, 65, 663–675. DePinho, R.A.; 5. Davis, R.J. Signal transduction by the JNK group of MAP kinases. Cell 2000, 103, 239–252. Panayotatos, N.; Cobb, M.H.; Yancopoulos, G.D. ERKs: A family of protein-serine/threonine kinases that are 6. Alessi, D.R.; activated and Gomez, tyrosineN.; Moorhead, G.;inLewis, phosphorylated responseT.; to Keyse, S.M.; insulin andCohen, NGF. CellP. Inactivation of p42 [CrossRef] 1991, 65, 663–675. MAP kinase 5. by protein Davis, phosphatase R.J. Signal 2A and transduction byathe protein tyrosine JNK group of phosphatase, MAP kinases.but Cellnot CL100, 2000, in various 103, 239–252. cell lines. Curr. [CrossRef] 6. Biol. 1995, Alessi, D.R.;5,Gomez, 283–295.N.; Moorhead, G.; Lewis, T.; Keyse, S.M.; Cohen, P. Inactivation of p42 MAP kinase by 7. protein phosphatase 2AT.and Saxena, M.; Mustelin, Extracellular signals phosphatase, a protein tyrosine and scores of but phosphatases: not CL100, in Allvarious roads lead to MAP cell lines. kinase. Curr. Biol. Semin. 1995, 5, Immunol. 2000, 12, 387–396. 283–295. [CrossRef] 7.8. Zhan, X.L.; Saxena, Wishart, M.J.; M.; Mustelin, Guan, K.L. Nonreceptor T. Extracellular tyrosine signals and scores phosphatases inAll of phosphatases: cellular roads signaling: lead to MAP Regulation kinase. of mitogen-activated Semin. Immunol. 2000,protein kinases. 12, 387–396. Chem. Rev. 2001, 101, 2477–2496. [CrossRef] 8.9. Kondoh, Zhan, X.L.;K.; Nishida, Wishart, E. Guan, M.J.; Regulation of MAP kinases K.L. Nonreceptor by MAP tyrosine kinase phosphatases. phosphatases Biochim.Regulation in cellular signaling: Biophys. Acta of 2007, 1773, 1227–1237. mitogen-activated protein kinases. Chem. Rev. 2001, 101, 2477–2496. [CrossRef] 9.10. Kholodenko, Kondoh, B.N.; Birtwistle, K.; Nishida, M.R. Four-dimensional E. Regulation of MAP kinases bydynamics MAP kinase of MAPK information phosphatases. processing Biochim. systems. Biophys. Acta Wiley1773, 2007, Interdiscip. Rev. Syst. 1227–1237. Biol. Med. 2009, 1, 28–44. [CrossRef] 11. 10. Seger, R.; Krebs, Kholodenko, B.N.;E.G. The MAPK Birtwistle, M.R.signaling cascade. FASEB Four-dimensional dynamicsJ. 1995, 9, 726–735. of MAPK information processing systems. 12. Wagner, Wiley E.F.; Nebreda, Interdiscip. Rev. Syst.A.R. Signal Biol. Med.integration by JNK 2009, 1, 28–44. and p38 MAPK pathways in cancer development. [CrossRef] 11. Nat. Rev. Seger, Cancer E.G. R.; Krebs, 2009,The9, 537–549. MAPK signaling cascade. FASEB J. 1995, 9, 726–735. [CrossRef] [PubMed] 13. Green, D.R.; Llambi, F. Cell Death Signaling. Cold Spring Harb. Perspect. Biol. 2015, 7, a006080. 14. Cuenda, A.; Rousseau, S. p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim. Biophys. Acta 2007, 1773, 1358–1375. Int. J. Mol. Sci. 2020, 21, 2346 16 of 22 12. Wagner, E.F.; Nebreda, A.R. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 2009, 9, 537–549. [CrossRef] [PubMed] 13. Green, D.R.; Llambi, F. Cell Death Signaling. Cold Spring Harb. Perspect. Biol. 2015, 7, a006080. [CrossRef] [PubMed] 14. Cuenda, A.; Rousseau, S. p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim. Biophys. Acta 2007, 1773, 1358–1375. [CrossRef] 15. Zeke, A.; Misheva, M.; Remenyi, A.; Bogoyevitch, M.A. JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships. Microbiol. Mol. Biol. Rev. 2016, 80, 793–835. [CrossRef] 16. Dhanasekaran, D.N.; Reddy, E.P. JNK signaling in apoptosis. Oncogene 2008, 27, 6245–6251. [CrossRef] 17. Dérijard, B.; Hibi, M.; Wu, I.H.; Barrett, T.; Su, B.; Deng, T.; Karin, M.; Davis, R.J. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994, 76, 1025–1037. [CrossRef] 18. Pramanik, R.; Qi, X.; Borowicz, S.; Choubey, D.; Schultz, R.M.; Han, J.; Chen, G. p38 isoforms have opposite effects on AP-1-dependent transcription through regulation of c-Jun. The determinant roles of the isoforms in the p38 MAPK signal specificity. J. Biol. Chem. 2003, 278, 4831–4839. [CrossRef] 19. Angel, P.; Hattori, K.; Smeal, T.; Karin, M. The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 1988, 55, 875–885. [CrossRef] 20. Shaulian, E.; Karin, M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 2002, 4, E131–E136. [CrossRef] 21. Eferl, R.; Wagner, E.F. AP-1: A double-edged sword in tumorigenesis. Nat. Rev. Cancer 2003, 3, 859–868. [CrossRef] [PubMed] 22. Ameyar, M.; Wisniewska, M.; Weitzman, J.B. A role for AP-1 in apoptosis: The case for and against. Biochimie 2003, 85, 747–752. [CrossRef] [PubMed] 23. Fuchs, S.Y.; Adler, V.; Pincus, M.R.; Ronai, Z. MEKK1/JNK signaling stabilizes and activates p53. Proc. Natl. Acad. Sci. USA 1998, 95, 10541–10546. [CrossRef] [PubMed] 24. Wolf, E.R.; McAtarsney, C.P.; Bredhold, K.E.; Kline, A.M.; Mayo, L.D. Mutant and wild-type p53 form complexes with p73 upon phosphorylation by the kinase JNK. Sci. Signal. 2018, 11, eeaao4170. [CrossRef] [PubMed] 25. Perfettini, J.-L.; Castedo, M.; Nardacci, R.; Ciccosanti, F.; Boya, P.; Roumier, T.; Larochette, N.; Piacentini, M.; Kroemer, G. Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope. J. Exp. Med. 2005, 201, 279–289. [CrossRef] 26. Cuadrado, A.; Lafarga, V.; Cheung, P.C.; Dolado, I.; Llanos, S.; Cohen, P.; Nebreda, A.R. A new p38 MAP kinase-regulated transcriptional coactivator that stimulates p53-dependent apoptosis. EMBO J. 2007, 26, 2115–2126. [CrossRef] 27. Shi, Y.; Nikulenkov, F.; Zawacka-Pankau, J.; Li, H.; Gabdoulline, R.; Xu, J.; Eriksson, S.; Hedström, E.; Issaeva, N.; Kel, A.; et al. ROS-dependent activation of JNK converts p53 into an efficient inhibitor of oncogenes leading to robust apoptosis. Cell Death Differ. 2014, 21, 612–623. [CrossRef] 28. Taylor, C.A.; Zheng, Q.; Liu, Z.; Thompson, J.E. Role of p38 and JNK MAPK signaling pathways and tumor suppressor p53 on induction of apoptosis in response to Ad-eIF5A1 in A549 lung cancer cells. Mol. Cancer 2013, 12, 35. [CrossRef] 29. Hu, K.; Gong, X.; Ai, Q.; Lin, L.; Dai, J.; Cai, L.; Jiang, R.; Ge, P.; Zhang, L. Endogenous AMPK acts as a detrimental factor in fulminant hepatitis via potentiating JNK-dependent hepatocyte apoptosis. Cell Death Dis. 2017, 8, e2637. [CrossRef] 30. Weng, Q.; Liu, Z.; Li, B.; Liu, K.; Wu, W.; Liu, H. Oxidative Stress Induces Mouse Follicular Granulosa Cells Apoptosis via JNK/FoxO1 Pathway. PLoS ONE 2016, 11, e0167869. [CrossRef] 31. Youle, R.J.; Strasser, A. The BCL-2 protein family: Opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 2008, 9, 47–59. [CrossRef] 32. Chang, L.; Kamata, H.; Solinas, G.; Luo, J.L.; Maeda, S.; Venuprasad, K.; Liu, Y.C.; Karin, M. The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell 2006, 124, 601–613. [CrossRef] 33. Deng, Y.; Ren, X.; Yang, L.; Lin, Y.; Wu, X. A JNK-dependent pathway is required for TNFalpha-induced apoptosis. Cell 2003, 115, 61–70. [CrossRef] Int. J. Mol. Sci. 2020, 21, 2346 17 of 22 34. Prakasam, A.; Ghose, S.; Oleinik, N.V.; Bethard, J.R.; Peterson, Y.K.; Krupenko, N.I.; Krupenko, S.A. JNK1/2 regulate Bid by direct phosphorylation at Thr59 in response to ALDH1L1. Cell Death Dis. 2014, 5, e1358. [CrossRef] [PubMed] 35. Yu, L.; Alva, A.; Su, H.; Dutt, P.; Freundt, E.; Welsh, S.; Baehrecke, E.H.; Lenardo, M.J. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 2004, 304, 1500–1502. [CrossRef] [PubMed] 36. Doherty, J.; Baehrecke, E.H. Life, death and autophagy. Nat. Cell Biol. 2018, 20, 1110–1117. [CrossRef] [PubMed] 37. Denton, D.; Kumar, S. Autophagy-dependent cell death. Cell Death Differ. 2019, 26, 605–616. [CrossRef] [PubMed] 38. Dhanasekaran, D.N.; Reddy, E.P. JNK-signaling: A multiplexing hub in programmed cell death. Genes Cancer 2017, 8, 682–694. 39. Slobodnyuk, K.; Radic, N.; Ivanova, S.; Llado, A.; Trempolec, N.; Zorzano, A.; Nebreda, A.R. Autophagy-induced senescence is regulated by p38α signaling. Cell Death Dis. 2019, 10, 376. [CrossRef] 40. Tsuruta, F.; Sunayama, J.; Mori, Y.; Hattori, S.; Shimizu, S.; Tsujimoto, Y.; Yoshioka, K.; Masuyama, N.; Gotoh, Y. JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins. EMBO J. 2004, 23, 1889–1899. [CrossRef] 41. Sunayama, J.; Tsuruta, F.; Masuyama, N.; Gotoh, Y. JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3. J. Cell Biol. 2005, 170, 295–304. [CrossRef] [PubMed] 42. Donovan, N.; Becker, E.B.E.; Konishi, Y.; Bonni, A. JNK phosphorylation and activation of BAD couples the stress-activated signaling pathway to the cell death machinery. J. Biol. Chem. 2002, 277, 40944–40949. [CrossRef] [PubMed] 43. Kim, B.-J.; Ryu, S.-W.; Song, B.-J. JNK- and p38 kinase-mediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells. J. Biol. Chem. 2006, 281, 21256–21265. [CrossRef] [PubMed] 44. Putcha, G.V.; Le, S.; Frank, S.; Besirli, C.G.; Clark, K.; Chu, B.; Alix, S.; Youle, R.J.; LaMarche, A.; Maroney, A.C.; et al. JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptosis. Neuron 2003, 38, 899–914. [CrossRef] 45. Cai, B.; Chang, S.H.; Becker, E.B.; Bonni, A.; Xia, Z. p38 MAP kinase mediates apoptosis through phosphorylation of BimEL at Ser-65. J. Biol. Chem. 2006, 281, 25215–25222. [CrossRef] [PubMed] 46. Lei, K.; Davis, R.J. JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc. Natl. Acad. Sci. USA 2003, 100, 2432–2437. [CrossRef] 47. Srivastava, R.K.; Mi, Q.S.; Hardwick, J.M.; Longo, D.L. Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis. Proc. Natl. Acad. Sci. USA 1999, 96, 3775–3780. [CrossRef] 48. Yamamoto, K.; Ichijo, H.; Korsmeyer, S.J. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol. Cell. Biol. 1999, 19, 8469–8478. [CrossRef] 49. Inoshita, S.; Takeda, K.; Hatai, T.; Terada, Y.; Sano, M.; Hata, J.; Umezawa, A.; Ichijo, H. Phosphorylation and inactivation of myeloid cell leukemia 1 by JNK in response to oxidative stress. J. Biol. Chem. 2002, 277, 43730–43734. [CrossRef] 50. Farley, N.; Pedraza-Alva, G.; Serrano-Gomez, D.; Nagaleekar, V.; Aronshtam, A.; Krahl, T.; Thornton, T.; Rincon, M. p38 mitogen-activated protein kinase mediates the Fas-induced mitochondrial death pathway in CD8+ T cells. Mol. Cell. Biol. 2006, 26, 2118–2129. [CrossRef] 51. Moriyama, M.; Moriyama, H.; Uda, J.; Kubo, H.; Nakajima, Y.; Goto, A.; Morita, T.; Hayakawa, T. BNIP3 upregulation via stimulation of ERK and JNK activity is required for the protection of keratinocytes from UVB-induced apoptosis. Cell Death Dis. 2017, 8, e2576. [CrossRef] [PubMed] 52. Brown, M.; Strudwick, N.; Suwara, M.; Sutcliffe, L.K.; Mihai, A.D.; Ali, A.A.; Watson, J.N.; Schroder, M. An initial phase of JNK activation inhibits cell death early in the endoplasmic reticulum stress response. J. Cell Sci. 2016, 129, 2317–2328. [CrossRef] [PubMed] 53. Li, Z.; Meng, Z.; Lu, J.; Chen, F.M.; Wong, W.T.; Tse, G.; Zheng, C.; Keung, W.; Tse, K.; Li, R.A.; et al. TRPV6 protects ER stress-induced apoptosis via ATF6α-TRPV6-JNK pathway in human embryonic stem cell-derived cardiomyocytes. J. Mol. Cell. Cardiol. 2018, 120, 1–11. [CrossRef] [PubMed] Int. J. Mol. Sci. 2020, 21, 2346 18 of 22 54. Feng, X.; Liu, H.; Zhang, Z.; Gu, Y.; Qiu, H.; He, Z. Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells. J. Exp. Clin. Cancer Res. 2017, 36, 123. [CrossRef] [PubMed] 55. Shao, Q.; Han, F.; Peng, S.; He, B. Nur77 inhibits oxLDL induced apoptosis of macrophages via the p38 MAPK signaling pathway. Biochem. Biophys. Res. Commun. 2016, 471, 633–638. [CrossRef] 56. Allan, L.A.; Morrice, N.; Brady, S.; Magee, G.; Pathak, S.; Clarke, P.R. Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK. Nat. Cell Biol. 2003, 5, 647–654. [CrossRef] 57. Seifert, A.; Clarke, P.R. p38alpha- and DYRK1A-dependent phosphorylation of caspase-9 at an inhibitory site in response to hyperosmotic stress. Cell. Signal. 2009, 21, 1626–1633. [CrossRef] 58. Tran, T.H.; Andreka, P.; Rodrigues, C.O.; Webster, K.A.; Bishopric, N.H. Jun kinase delays caspase-9 activation by interaction with the apoptosome. J. Biol. Chem. 2007, 282, 20340–20350. [CrossRef] 59. Yu, C.; Minemoto, Y.; Zhang, J.; Liu, J.; Tang, F.; Bui, T.N.; Xiang, J.; Lin, A. JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family protein BAD. Mol. Cell 2004, 13, 329–340. [CrossRef] 60. Menon, M.B.; Gropengießer, J.; Fischer, J.; Novikova, L.; Deuretzbacher, A.; Lafera, J.; Schimmeck, H.; Czymmeck, N.; Ronkina, N.; Kotlyarov, A.; et al. p38/MK2-dependent phosphorylation controls cytotoxic RIPK1 signalling in inflammation and infection. Nat. Cell Biol. 2017, 19, 1248–1259. [CrossRef] 61. Muniyappa, H.; Das, K.C. Activation of c-Jun N-terminal kinase (JNK) by widely used specific p38 MAPK inhibitors SB202190 and SB203580: A MLK-3-MKK7-dependent mechanism. Cell. Signal. 2008, 20, 675–683. [CrossRef] [PubMed] 62. Hui, L.; Bakiri, L.; Mairhorfer, A.; Schweifer, N.; Haslinger, C.; Kenner, L.; Komnenovic, V.; Scheuch, H.; Beug, H.; Wagner, E.F. p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway. Nat. Genet. 2007, 39, 741–749. [CrossRef] [PubMed] 63. Wada, T.; Stepniak, E.; Hui, L.; Leibbrandt, A.; Katada, T.; Nishina, H.; Wagner, E.F.; Penninger, J.M. Antagonistic control of cell fates by JNK and p38-MAPK signaling. Cell Death Differ. 2008, 15, 89–93. [CrossRef] [PubMed] 64. Staples, C.J.; Owens, D.M.; Maier, J.V.; Cato, A.C.B.; Keyse, S.M. Cross-talk between the p38alpha and JNK MAPK pathways mediated by MAP kinase phosphatase-1 determines cellular sensitivity to UV radiation. J. Biol. Chem. 2010, 285, 25928–25940. [CrossRef] 65. Miura, H.; Kondo, Y.; Matsuda, M.; Aoki, K. Cell-to-Cell Heterogeneity in p38-Mediated Cross-Inhibition of JNK Causes Stochastic Cell Death. Cell Rep. 2018, 24, 2658–2668. [CrossRef] 66. Balmanno, K.; Cook, S.J. Tumour cell survival signalling by the ERK1/2 pathway. Cell Death Differ. 2009, 16, 368–377. [CrossRef] 67. Lu, Z.; Xu, S. ERK1/2 MAP kinases in cell survival and apoptosis. IUBMB Life 2006, 58, 621–631. [CrossRef] 68. Cagnol, S.; Chambard, J.-C. ERK and cell death: Mechanisms of ERK-induced cell death-apoptosis, autophagy and senescence. FEBS J. 2010, 277, 2–21. [CrossRef] 69. Liu, Z.; Ruan, H.J.; Gu, P.Q.; Ding, W.Y.; Luo, X.H.; Huang, R.; Zhao, W.; Gao, L.J. The Roles of p38 MAPK and ERK1/2 in Coplanar Polychlorinated Biphenyls-Induced Apoptosis of Human Extravillous Cytotrophoblast-Derived Transformed Cells. Cell. Physiol. Biochem. 2015, 36, 2418–2432. [CrossRef] 70. Astuti, P.; Pike, T.; Widberg, C.; Payne, E.; Harding, A.; Hancock, J.; Gabrielli, B. MAPK pathway activation delays G2/M progression by destabilizing Cdc25B. J. Biol. Chem. 2009, 284, 33781–33788. [CrossRef] 71. Modi, P.K.; Komaravelli, N.; Singh, N.; Sharma, P. Interplay between MEK-ERK signaling, cyclin D1, and cyclin-dependent kinase 5 regulates cell cycle reentry and apoptosis of neurons. Mol. Biol. Cell 2012, 23, 3722–3730. [CrossRef] [PubMed] 72. Persons, D.L.; Yazlovitskaya, E.M.; Pelling, J.C. Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin. J. Biol. Chem. 2000, 275, 35778–35785. [CrossRef] [PubMed] 73. Lee, Y.J.; Choi, S.Y.; Yang, J.H. NMDA receptor-mediated ERK 1/2 pathway is involved in PFHxS-induced apoptosis of PC12 cells. Sci. Total Environ. 2014, 491–492, 227–234. [CrossRef] [PubMed] 74. Dubey, N.K.; Peng, B.-Y.; Lin, C.-M.; Wang, P.D.; Wang, J.R.; Chan, C.-H.; Wei, H.-J.; Deng, W.-P. NSC 95397 Suppresses Proliferation and Induces Apoptosis in Colon Cancer Cells through MKP-1 and the ERK1/2 Pathway. Int. J. Mol. Sci. 2018, 19, 1625. [CrossRef] [PubMed] 75. Stanciu, M.; Wang, Y.; Kentor, R.; Burke, N.; Watkins, S.; Kress, G.; Reynolds, I.; Klann, E.; Angiolieri, M.R.; Johnson, J.W.; et al. Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J. Biol. Chem. 2000, 275, 12200–12206. [CrossRef] [PubMed] Int. J. Mol. Sci. 2020, 21, 2346 19 of 22 76. Jara, J.H.; Singh, B.B.; Floden, A.M.; Combs, C.K. Tumor necrosis factor alpha stimulates NMDA receptor activity in mouse cortical neurons resulting in ERK-dependent death. J. Neurochem. 2007, 100, 1407–1420. [CrossRef] [PubMed] 77. Pyakurel, A.; Savoia, C.; Hess, D.; Scorrano, L. Extracellular regulated kinase phosphorylates mitofusin 1 to control mitochondrial morphology and apoptosis. Mol. Cell 2015, 58, 244–254. [CrossRef] 78. López, J.M. Digital kinases: A cell model for sensing, integrating and making choices. Commun. Integr. Biol. 2010, 3, 146–150. [CrossRef] 79. Ferrell, J.E.; Ha, S.H. Ultrasensitivity part I: Michaelian responses and zero-order ultrasensitivity. Trends Biochem. Sci. 2014, 39, 496–503. [CrossRef] 80. Ferrell, J.E.; Ha, S.H. Ultrasensitivity part II: Multisite phosphorylation, stoichiometric inhibitors, and positive feedback. Trends Biochem. Sci. 2014, 39, 556–569. [CrossRef] 81. Brandman, O.; Meyer, T. Feedback loops shape cellular signals in space and time. Science 2008, 322, 390–395. [CrossRef] [PubMed] 82. Ferrell, J.E.; Machleder, E.M. The biochemical basis of an all-or-none cell fate switch in Xenopus oocytes. Science 1998, 280, 895–898. [CrossRef] [PubMed] 83. Ferrell, J.E. Self-perpetuating states in signal transduction: Positive feedback, double-negative feedback and bistability. Curr. Opin. Cell Biol. 2002, 14, 140–148. [CrossRef] 84. Ferrell, J.E.; Ha, S.H. Ultrasensitivity part III: Cascades, bistable switches, and oscillators. Trends Biochem. Sci. 2014, 39, 612–618. [CrossRef] 85. Bagowski, C.P.; Ferrell, J.E., Jr. Bistability in the JNK cascade. Curr. Biol. 2001, 11, 1176–1182. [CrossRef] 86. Xiong, W.; Ferrell, J.E. A positive-feedback-based bistable ‘memory module’ that governs a cell fate decision. Nature 2003, 426, 460–465. [CrossRef] 87. Ben Messaoud, N.; Katzarova, I.; López, J.M. Basic Properties of the p38 Signaling Pathway in Response to Hyperosmotic Shock. PLoS ONE 2015, 10, e0135249. [CrossRef] 88. Bagowski, C.P.; Besser, J.; Frey, C.R.; Ferrell, J.E. The JNK cascade as a biochemical switch in mammalian cells: Ultrasensitive and all-or-none responses. Curr. Biol. 2003, 13, 315–320. [CrossRef] 89. Mackeigan, J.P.; Murphy, L.O.; Dimitri, C.A.; Blenis, J. Graded mitogen-activated protein kinase activity precedes switch-like c-Fos induction in mammalian cells. Mol. Cell. Biol. 2005, 25, 4676–4682. [CrossRef] 90. Pelet, S.; Rudolf, F.; Nadal-Ribelles, M.; de Nadal, E.; Posas, F.; Peter, M. Transient activation of the HOG MAPK pathway regulates bimodal gene expression. Science 2011, 332, 732–735. [CrossRef] 91. Martiáñez, T.; Francès, S.; López, J.M. Generation of digital responses in stress sensors. J. Biol. Chem. 2009, 284, 23902–23911. [CrossRef] [PubMed] 92. Ventura, J.-J.; Hübner, A.; Zhang, C.; Flavell, R.A.; Shokat, K.M.; Davis, R.J. Chemical genetic analysis of the time course of signal transduction by JNK. Mol. Cell 2006, 21, 701–710. [CrossRef] [PubMed] 93. Tobiume, K.; Matsuzawa, A.; Takahashi, T.; Nishitoh, H.; Morita, K.; Takeda, K.; Minowa, O.; Miyazono, K.; Noda, T.; Ichijo, H. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep. 2001, 2, 222–228. [CrossRef] [PubMed] 94. Roulston, A.; Reinhard, C.; Amiri, P.; Williams, L.T. Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha. J. Biol. Chem. 1998, 273, 10232–10239. [CrossRef] 95. Nagata, Y.; Todokoro, K. Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis. Blood 1999, 94, 853–863. [CrossRef] 96. Vendrell, A.; Martínez-Pastor, M.; González-Novo, A.; Pascual-Ahuir, A.; Sinclair, D.A.; Proft, M.; Posas, F. Sir2 histone deacetylase prevents programmed cell death caused by sustained activation of the Hog1 stress-activated protein kinase. EMBO Rep. 2011, 12, 1062–1068. [CrossRef] 97. Murphy, L.O.; Blenis, J. MAPK signal specificity: The right place at the right time. Trends Biochem. Sci. 2006, 31, 268–275. [CrossRef] 98. Alonso, G.; Ambrosino, C.; Jones, M.; Nebreda, A.R. Differential activation of p38 mitogen-activated protein kinase isoforms depending on signal strength. J. Biol. Chem. 2000, 275, 40641–40648. [CrossRef] 99. Swaffer, M.P.; Jones, A.W.; Flynn, H.R.; Snijders, A.P.; Nurse, P. CDK Substrate Phosphorylation and Ordering the Cell Cycle. Cell 2016, 167, 1750–1761. [CrossRef] Int. J. Mol. Sci. 2020, 21, 2346 20 of 22 100. Godfrey, M.; Touati, S.A.; Kataria, M.; Jones, A.; Snijders, A.P.; Uhlmann, F. PP2A Phosphatase Imposes Ordered Cell-Cycle Phosphorylation by Opposing Threonine Phosphorylation. Mol. Cell 2017, 65, 393–402. [CrossRef] 101. Kamenz, J.; Ferrell, J.E. The Temporal Ordering of Cell-Cycle Phosphorylation. Mol. Cell 2017, 65, 371–373. [CrossRef] [PubMed] 102. Hofstadter, D.R. I Am a Strange Loop; Basic Books: New York, NY, USA, 2007. 103. Freeman, M. Feedback control of intercellular signalling in development. Nature 2000, 408, 313–319. [CrossRef] [PubMed] 104. Schoenheimer, R.; Breusch, F. Synthesis and destruction of cholesterol in the organism. J. Biol. Chem. 1933, 103, 439–448. 105. Massé, E.; Arguin, M. Ironing out the problem: New mechanisms of iron homeostasis. Trends Biochem. Sci. 2005, 30, 462–468. [CrossRef] [PubMed] 106. Ferrell, J.E. Feedback loops and reciprocal regulation: Recurring motifs in the systems biology of the cell cycle. Curr. Opin. Cell Biol. 2013, 25, 676–686. [CrossRef] [PubMed] 107. Ingolia, N.T.; Murray, A.W. Positive-feedback loops as a flexible biological module. Curr. Biol. 2007, 17, 668–677. [CrossRef] [PubMed] 108. Kirsch, D.G.; Doseff, A.; Chau, B.N.; Lim, D.S.; de Souza-Pinto, N.C.; Hansford, R.; Kastan, M.B.; Lazebnik, Y.A.; Hardwick, J.M. Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c. J. Biol. Chem. 1999, 274, 21155–21161. [CrossRef] 109. Cowling, V.; Downward, J. Caspase-6 is the direct activator of caspase-8 in the cytochrome c-induced apoptosis pathway: Absolute requirement for removal of caspase-6 prodomain. Cell Death Differ. 2002, 9, 1046–1056. [CrossRef] 110. Slee, E.A.; Keogh, S.A.; Martin, S.J. Cleavage of BID during cytotoxic drug and UV radiation-induced apoptosis occurs downstream of the point of Bcl-2 action and is catalysed by caspase-3: A potential feedback loop for amplification of apoptosis-associated mitochondrial cytochrome c release. Cell Death Differ. 2000, 7, 556–565. [CrossRef] 111. Yue, J.; Ben Messaoud, N.; López, J.M. Hyperosmotic Shock Engages Two Positive Feedback Loops through Caspase-3-dependent Proteolysis of JNK1-2 and Bid. J. Biol. Chem. 2015, 290, 30375–30389. [CrossRef] 112. Fujita, E.; Egashira, J.; Urase, K.; Kuida, K.; Momoi, T. Caspase-9 processing by caspase-3 via a feedback amplification loop in vivo. Cell Death Differ. 2001, 8, 335–344. [CrossRef] [PubMed] 113. Denault, J.B.; Eckelman, B.P.; Shin, H.; Pop, C.; Salvesen, G.S. Caspase 3 attenuates XIAP (X-linked inhibitor of apoptosis protein)-mediated inhibition of caspase 9. Biochem. J. 2007, 405, 11–19. [CrossRef] [PubMed] 114. Twiddy, D.; Cain, K. Caspase-9 cleavage, do you need it? Biochem. J. 2007, 405, e1–e2. [CrossRef] 115. Stennicke, H.R.; Jürgensmeier, J.-M.; Shin, H.; Deveraux, Q.; Wolf, B.B.; Yang, X.; Zhou, Q.; Ellerby, H.M.; Ellerby, L.M.; Bredesen, D.; et al. Pro-caspase-3 is a major physiologic target of caspase-8. J. Biol. Chem. 1998, 273, 27084–27090. [CrossRef] [PubMed] 116. McComb, S.; Chan, P.K.; Guinot, A.; Hartmannsdottir, H.; Jenni, S.; Dobay, M.P.; Bourquin, J.P.; Bornhauser, B.C. Efficient apoptosis requires feedback amplification of upstream apoptotic signals by effector caspase-3 or -7. Sci. Adv. 2019, 5, eaau9433. [CrossRef] 117. Kurokawa, M.; Kornbluth, S. Caspases and kinases in a death grip. Cell 2009, 138, 838–854. [CrossRef] [PubMed] 118. Cuenda, A.; Dorow, D.S. Differential activation of stress-activated protein kinase kinases SKK4/MKK7 and SKK1/MKK4 by the mixed-lineage kinase-2 and mitogen-activated protein kinase kinase (MKK) kinase-1. Biochem. J. 1998, 333, 11–15. [CrossRef] [PubMed] 119. Cardone, M.H.; Salvesen, G.S.; Widmann, C.; Johnson, G.; Frisch, S.M. The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell 1997, 90, 315–323. [CrossRef] 120. Deak, J.C.; Cross, J.V.; Lewis, M.; Qian, Y.; Parrott, L.A.; Distelhorst, C.W.; Templeton, D.J. Fas-induced proteolytic activation and intracellular redistribution of the stress-signaling kinase MEKK1. Proc. Natl. Acad. Sci. USA 1998, 95, 5595–5600. [CrossRef] [PubMed] 121. Widmann, C.; Gerwins, P.; Johnson, N.L.; Jarpe, M.B.; Johnson, G.L. MEK kinase 1, a substrate for DEVD-directed caspases, is involved in genotoxin-induced apoptosis. Mol. Cell. Biol. 1998, 18, 2416–2429. [CrossRef] [PubMed] Int. J. Mol. Sci. 2020, 21, 2346 21 of 22 122. Zeng, K.W.; Song, F.J.; Wang, Y.H.; Li, N.; Yu, Q.; Liao, L.X.; Jiang, Y.; Tu, P.F. Induction of hepatoma carcinoma cell apoptosis through activation of the JNK-nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-ROS self-driven death signal circuit. Cancer Lett. 2014, 353, 220–231. [CrossRef] [PubMed] 123. Xu, C.; Wang, X.; Gu, C.; Zhang, H.; Zhang, R.; Dong, X.; Liu, C.; Hu, X.; Ji, X.; Huang, S.; et al. Celastrol ameliorates Cd-induced neuronal apoptosis by targeting NOX2-derived ROS-dependent PP5-JNK signaling pathway. J. Neurochem. 2017, 141, 48–62. [CrossRef] [PubMed] 124. Bragado, P.; Armesilla, A.; Silva, A.; Porras, A. Apoptosis by cisplatin requires p53 mediated p38alpha MAPK activation through ROS generation. Apoptosis 2007, 12, 1733–1742. [CrossRef] [PubMed] 125. Trempolec, N.; Muñoz, J.P.; Slobodnyuk, K.; Marin, S.; Cascante, M.; Zorzano, A.; Nebreda, A.R. Induction of oxidative metabolism by the p38α/MK2 pathway. Sci. Rep. 2017, 7, 11367. [CrossRef] 126. Zhang, X.; Wang, X.; Wu, T.; Li, B.; Liu, T.; Wang, R.; Liu, Q.; Liu, Z.; Gong, Y.; Shao, C. Isoliensinine induces apoptosis in triple-negative human breast cancer cells through ROS generation and p38 MAPK/JNK activation. Sci. Rep. 2015, 5, 12579. [CrossRef] 127. Matsuzawa, A.; Ichijo, H. Redox control of cell fate by MAP kinase: Physiological roles of ASK1-MAP kinase pathway in stress signaling. Biochim. Biophys. Acta 2008, 1780, 1325–1336. [CrossRef] 128. Dyari, H.R.E.; Rawling, T.; Chen, Y.; Sudarmana, W.; Bourget, K.; Dwyer, J.M.; Allison, S.E.; Murray, M. A novel synthetic analogue of ω-3 17,18-epoxyeicosatetraenoic acid activates TNF receptor-1/ASK1/JNK signaling to promote apoptosis in human breast cancer cells. FASEB J. 2017, 31, 5246–5257. [CrossRef] 129. Kitamura, T.; Fukuyo, Y.; Inoue, M.; Horikoshi, N.T.; Shindoh, M.; Rogers, B.E.; Usheva, A.; Horikoshi, N. Mutant p53 disrupts the stress MAPK activation circuit induced by ASK1-dependent stabilization of Daxx. Cancer Res. 2009, 69, 7681–7688. [CrossRef] 130. Hayakawa, Y.; Hirata, Y.; Nakagawa, H.; Sakamoto, K.; Hikiba, Y.; Kinoshita, H.; Nakata, W.; Takahashi, R.; Tateishi, K.; Tada, M.; et al. Apoptosis signal-regulating kinase 1 and cyclin D1 compose a positive feedback loop contributing to tumor growth in gastric cancer. Proc. Natl. Acad. Sci. USA 2011, 108, 780–785. [CrossRef] 131. Chen, C.L.; Lin, C.F.; Chang, W.T.; Huang, W.C.; Teng, C.F.; Lin, Y.S. Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway. Blood 2008, 111, 4365–4374. [CrossRef] 132. Yabu, T.; Shiba, H.; Shibasaki, Y.; Nakanishi, T.; Imamura, S.; Touhata, K.; Yamashita, M. Stress-induced ceramide generation and apoptosis via the phosphorylation and activation of nSMase1 by JNK signaling. Cell Death Differ. 2015, 22, 258–273. [CrossRef] [PubMed] 133. Kluck, R.M.; Bossy-Wetzel, E.; Green, D.R.; Newmeyer, D.D. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 1997, 275, 1132–1136. [CrossRef] [PubMed] 134. Newmeyer, D.D.; Farschon, D.M.; Reed, J.C. Cell-free apoptosis in Xenopus egg extracts: Inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria. Cell 1994, 79, 353–364. [CrossRef] 135. Braun, T.; Dar, S.; Vorobiov, D.; Lindenboim, L.; Dascal, N.; Stein, R. Expression of Bcl-x(S) in Xenopus oocytes induces BH3-dependent and caspase-dependent cytochrome c release and apoptosis. Mol. Cancer Res. 2003, 1, 186–194. [PubMed] 136. Nutt, L.K.; Margolis, S.S.; Jensen, M.; Herman, C.E.; Dunphy, W.G.; Rathmell, J.C.; Kornbluth, S. Metabolic regulation of oocyte cell death through the CaMKII-mediated phosphorylation of caspase-2. Cell 2005, 123, 89–103. [CrossRef] [PubMed] 137. Coll, O.; Morales, A.; Fernández-Checa, J.C.; Garcia-Ruiz, C. Neutral sphingomyelinase-induced ceramide triggers germinal vesicle breakdown and oxidant-dependent apoptosis in Xenopus laevis oocytes. J. Lipid Res. 2007, 48, 1924–1935. [CrossRef] [PubMed] 138. Nutt, L.K. The Xenopus oocyte: A model for studying the metabolic regulation of cancer cell death. Semin. Cell Dev. Biol. 2012, 23, 412–418. [CrossRef] [PubMed] 139. Du Pasquier, D.; Dupré, A.; Jessus, C. Unfertilized Xenopus eggs die by Bad-dependent apoptosis under the control of Cdk1 and JNK. PLoS ONE 2011, 6, e23672. [CrossRef] [PubMed] 140. Bhuyan, A.K.; Varshney, A.; Mathew, M.K. Resting membrane potential as a marker of apoptosis: Studies on Xenopus oocytes microinjected with cytochrome c. Cell Death Differ. 2001, 8, 63–69. [CrossRef] 141. Cheng, X.; Ferrell, J.E. Apoptosis propagates through the cytoplasm as trigger waves. Science 2018, 361, 607–612. [CrossRef] [PubMed] 142. Burg, M.B.; Ferraris, J.D.; Dmitrieva, N.I. Cellular response to hyperosmotic stresses. Physiol. Rev. 2007, 87, 1441–1474. [CrossRef] Int. J. Mol. Sci. 2020, 21, 2346 22 of 22 143. Brocker, C.; Thompson, D.C.; Vasiliou, V. The role of hyperosmotic stress in inflammation and disease. Biomol. Concepts 2012, 3, 345–364. [CrossRef] [PubMed] 144. Bortner, C.D.; Cidlowski, J.A. Absence of volume regulatory mechanisms contributes to the rapid activation of apoptosis in thymocytes. Am. J. Physiol. 1996, 271, C950–C961. [CrossRef] [PubMed] 145. Reinehr, R.; Becker, S.; Braun, J.; Eberle, A.; Grether-Beck, S.; Haüssinger, D. Endosomal acidification and activation of NADPH oxidase isoforms are upstream events in hyperosmolarity-induced hepatocyte apoptosis. J. Biol. Chem. 2006, 281, 23150–23166. [CrossRef] [PubMed] 146. Friis, M.B.; Friborg, C.R.; Schneider, L.; Nielsen, M.-B.; Lambert, I.H.; Christensen, S.T.; Hoffmann, E.K. Cell shrinkage as a signal to apoptosis in NIH 3T3 fibroblasts. J. Physiol. 2005, 567, 427–443. [CrossRef] 147. Criollo, A.; Galluzzi, L.; Maiuri, M.C.; Tasdemir, E.; Lavandero, S.; Kroemer, G. Mitochondrial control of cell death induced by hyperosmotic stress. Apoptosis 2007, 12, 3–18. [CrossRef] 148. Lang, K.S.; Myssina, S.; Brand, V.; Sandu, C.; Lang, P.A.; Berchtold, S.; Huber, S.M.; Lang, F.; Wieder, T. Involvement of ceramide in hyperosmotic shock-induced death of erythrocytes. Cell Death Differ. 2004, 11, 231–243. [CrossRef] 149. Ben Messaoud, N.; Yue, J.; Valent, D.; Katzarova, I.; López, J.M. Osmostress-induced apoptosis in Xenopus oocytes: Role of stress protein kinases, calpains and Smac/DIABLO. PLoS ONE 2015, 10, e0124482. [CrossRef] 150. Pörn-Ares, M.I.; Samali, A.; Orrenius, S. Cleavage of the calpain inhibitor, calpastatin, during apoptosis. Cell Death Differ. 1998, 5, 1028–1033. [CrossRef] 151. Wang, K.K.; Posmantur, R.; Nadimpalli, R.; Nath, R.; Mohan, P.; Nixon, R.A.; Talanian, R.V.; Keegan, M.; Herzog, L.; Allen, H. Caspase-mediated fragmentation of calpain inhibitor protein calpastatin during apoptosis. Arch. Biochem. Biophys. 1998, 356, 187–196. [CrossRef] 152. Brock, A.; Chang, H.; Huang, S. Non-genetic heterogeneity-a mutation-independent driving force for the somatic evolution of tumours. Nat. Rev. Genet. 2009, 10, 336–342. [CrossRef] [PubMed] 153. Spencer, S.L.; Gaudet, S.; Albeck, J.G.; Burke, J.M.; Sorger, P.K. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature 2009, 459, 428–432. [CrossRef] [PubMed] 154. Yue, J.; López, J.M. JNK does not regulate meiotic progression in Xenopus oocytes: The strange case of pJNK and pERK. Dev. Biol. 2016, 416, 42–51. [CrossRef] [PubMed] 155. Izumi, T.; Maller, J.L. Elimination of cdc2 phosphorylation sites in the cdc25 phosphatase blocks initiation of M-phase. Mol. Biol. Cell 1993, 4, 1337–1350. [CrossRef] 156. Abrieu, A.; Brassac, T.; Galas, S.; Fisher, D.; Labbé, J.C.; Dorée, M. The Polo-like kinase Plx1 is a component of the MPF amplification loop at the G2/M-phase transition of the cell cycle in Xenopus eggs. J. Cell Sci. 1998, 111, 1751–1757. 157. Keady, B.T.; Kuo, P.; Martínez, S.E.; Yuan, L.; Hake, L.E. MAPK interacts with XGef and is required for CPEB activation during meiosis in Xenopus oocytes. J. Cell Sci. 2007, 120, 1093–1103. [CrossRef] 158. Dupré, A.; Buffin, E.; Roustan, C.; Nairn, A.C.; Jessus, C.; Haccard, O. The phosphorylation of ARPP19 by Greatwall renders the auto-amplification of MPF independently of PKA in Xenopus oocytes. J. Cell Sci. 2013, 126, 3916–3926. [CrossRef] © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).